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ABSTRACT 
 
STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF ACETOACETATE DECARBOXYLASE-LIKE 
ENZYMES 
by 
Lisa S. Mueller 
The University of Wisconsin-Milwaukee, 2016 
Under the Supervision of Professor Nicholas R. Silvaggi 
 
 
 
The acetatoacetate decarboxylase-like superfamily (ADCSF) is a largely unexplored group 
of enzymes that may be a potential source of new biocatalysts. Bioinformatic analysis has 
grouped these approximately 2000 enzymes into seven different families based on comparison 
of predicted active site residues. To date, only the prototypical ADCs (Family I) that catalyze the 
decarboxylation of acetoacetate have been studied. Analysis of gene context suggests that Family 
V contains predominantly enzymes predicted to be involved in secondary metabolism. On 
average, these share about 20% sequence identity to the true ADCs. To learn more about the 
diversity of chemistries performed by members of Family V, we have been studying two enzymes 
annotated as "acetoacetate decarboxylase" in the GenBank database. These are Sbi_00515 from 
Streptomyces bingchenggensis and Swit_4259 from Sphingomonas wittichii. Steady state 
iii 
 
analyses of these enzymes demonstrate that both lack decarboxylase activity with any of the 
substrates tested. This was surprising given that the crystal structures of both enzymes show that 
their overall folds are almost indistinguishable from that of the prototypical ADCs, though the 
quaternary structures are different. An important observation from the bioinformatic and 
crystallographic analyses is that the catalytic lysine and putative acid/base catalyst residues of 
the true ADCs are retained in both groups of enzymes, but the active site architectures are 
different. Specifically, two residues shown to be important for the acetoacetate decarboxylase 
reaction, Arg29 and Glu61 in Clostridium acetobutylicum ADC (CaADC), are not retained in the 
Family V enzymes. Site-directed mutagenesis, steady state and transient kinetics, and mass 
spectroscopy data suggest evidence for reversible aldolase-dehydratase and retro-aldolase 
activities mediated through a Schiff-base mechanism. These are the first Schiff-base-forming 
aldolases that do not use the TIM barrel fold. Although the physiologically relevant reactions of 
these Family V enzymes are unknown, these studies illustrate that the ADC fold is a versatile 
platform that can be adapted to perform different chemistries. 
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CHAPTER I: INTRODUCTION 
1.1 Biocatalysis 
 Biocatalysts are attractive tools for green chemistry because they are naturally regio-, 
chemo-, and stereospecific, and have evolved to catalyze reactions under mild conditions in 
aqueous solvent 7. Green chemistry aims to reduce or eliminate the creation or usage of 
hazardous materials at all steps of chemical production, including reducing the environmental 
impact from of chemical production processes 8. It also aims to reduce resource usage by 
eliminating the need for high or low temperatures or pressures to facilitate catalysis. To date, 
more than 100 biocatalysts have been used in industrial applications 9, including the 
pharmaceutical manufacture of Sitagliptin 10, a drug used in the treatment of Type II diabetes, 
the production of high-fructose corn syrup 11, and environmental remediation, such as aromatic 
hydrocarbon degradation 12. In addition, biocatalysts can be used in research or diagnostic roles 
13. Another advantage for biocatalysts is that for a good candidate, they have about 100 % 
enantiomeric excess (ee) for chiral molecules. The choice of biocatalyst depends on a number of 
factors, including whole cells or isolated enzymes, the chemistry, substrate specificity, catalytic 
efficiency, and/or stability at various temperatures or in organic solvents 14. The paradox for 
enzymes in organic synthesis is that their specificity, their major strength, also limits their 
usefulness, because it is difficult to find an enzyme to do the required chemistry with the desired 
starting materials.  This limitation can be overcome by engineering an existing enzyme to fit a 
specific reaction, or by finding new enzymes with different activity or substrate specificity 
profiles. 
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 Finding the enzyme that catalyzes the desired reaction could obviate the need for enzyme 
engineering. In many cases, it is possible to find homologs of known enzymes with improved 
properties, such as altered substrate specificity, different stereochemistry of the product, altered 
pH or temperature optima, increased activity, and/or increased temperature or solvent stability. 
Genome mining has become an effective tool for identifying enzymes with potentially useful 
catalytic activities. The amino acid sequence of an enzyme of interest can be used to find 
homologous sequences in the database (e.g. the Basic Local Alignment Search Tool [BLAST]). 
Detailed analysis of the resulting multiple sequence alignments can lead to identification of 
differences in active site residues that may impact catalytic activity 15, 16. Nonetheless, functional 
annotation in sequence databases is often incomplete or wrong 17. The challenge remains to 
make an educated guess on protein function from sequence information alone. More 
information on potentially novel enzymes can be gleaned from sequence similarity networks 
(SSNs) and the genome neighborhood network (GNN) 18, 19. Other large scale initiatives to mine 
data range from protein-protein interactions 20, metabolic pathways 21, to databases specifically 
for bacteria, archaea, and fungi 22.  Once a new enzyme has been selected for study, it needs to 
be expressed, purified, and tested for activity, substrate specificity, and stability. During or after 
that process, the enzyme may need further engineering. 
1.2 Protein Engineering 
Protein engineering can proceed by three different methods, each with sub-techniques 
for altering protein properties to meet process conditions: (1) rational design, (2) directed 
evolution, and (3) computational design 13, 23. First, rational design uses structural and 
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mechanistic information, as well as molecular modeling for prediction of changes in the protein 
structure in order to change its properties 13. For instance, changing an active site Tyr to Phe by 
studying an X-ray crystallographic structure by site directed mutagenesis uses rational design. 
Next, directed evolution comprises of two major steps: random mutagenesis  of the gene 
encoding the enzyme, and identification of desired variants within the mutant library by 
screening or selection 13. The most common means of generating the necessary genetic variation 
are recombination-based methods (e.g. gene shuffling) and error-prone PCR. In gene shuffling, 
related genes are digested with Deoxyribonuclease I (DNase I) and reassembled by polymerase 
chain reaction (PCR) 24. This technique may take place in vitro or in vivo and relies on annealing 
of homologous sequences on separate fragments of the gene 25. Error-prone PCR is another way 
to achieve random mutagenesis in the hope of obtaining a protein variant with the desired 
properties. This in vitro technique takes advantage of a DNA polymerase without proof-reading 
ability, and/or manipulating the reaction conditions by adding divalent manganese or magnesium 
during PCR amplification of a gene, or unbalancing nucleotide concentrations 26, 27. All of these 
manipulations cause the polymerase to make far more mistakes than it would under optimal 
conditions. Site-directed saturation mutagenesis (SSM) combines elements of directed evolution 
with rational design. Rational design targets specific residues with potential roles in catalysis, 
substrate binding, or release. SSM samples all 20 of the proteinogenic amino acids at a limited 
number of positions that are identified in structural and/or enzyme kinetic studies of the parent 
enzyme. Lastly, computational tools like the HotSpot Wizard 13 also aid in the semi-rational design 
process. This computational algorithm takes into account the protein structure, hypothetically 
mutating residues in the active site or those lining access tunnels, hence “hot spots”, that the 
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user may choose to alter by site-directed mutagenesis 23, 28.  In the case where an experimental 
structure of a protein is not available in the Protein Data Bank (PDB), a homology model can be 
made. This takes the sequence of the protein of interest, combined with a known structure of a 
homologous protein with significant sequence identity 29. The backbone template with desired 
sequence can be used as a guide for making amino acid mutations. A recent publication has made 
the push for homology modeling and molecular docking together, which could greatly impact the 
residues to be mutated 30. 
Directed evolution and SSM can generate huge libraries, on the order of 106 ‒ 109 variants, 
all of which must be assayed for the property being optimized 31. Thus, the primary limitation in 
directed evolution experiments is the identification of mutants with desirable properties 32. A 
200 amino acid protein with two amino acid substitutions anywhere in the sequence generates 
7,183,900 possible variants, three mutations in the same protein produces 9,008,610,600 
possibilities 33. All variants can be screened, or a partial library can be analyzed, with further 
evolution done on the best mutants from the first library. High-throughput methods are 
necessary in order to resolve the mutants in a timely manner. Fluorescence-activated cell sorting 
(FACS) can monitor changes in substrate specificity and stereochemistry in a few hours, with up 
to 108 variants 34.  This method can be coupled to cell surface display, in vitro 
compartmentalization (IVC), or single cell compartmentalization 34. An in vivo selection method 
with FACS has also been described, by coupling an enantiomer to both a specific carbon source 
needed for growth and a toxic compound as a growth inhibitor to eliminate null mutation 35. A 
limitation of these approaches is that they are not run under realistic conditions; when subject 
to physiological conditions or substrates, the hits from FACS may not perform as expected 31. Two 
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recent papers have found a way around this, yet still incorporating fluorescence. Chen et al. 
developed microcapillary single-cell analysis and laser extraction (µSCALE), which begins with 
variant libraries expressed in bacteria (Escherichia coli) or yeast (Saccharomyces cerevisiae) 36. 
The method sorted single cells into a microcapillary, and fluorescence microscopy is used on the 
microcapillary array. The microscope can detect emitting antibodies bound on the surface of a 
yeast cell, fluorescent proteins in E. coli cells, or real-time kinetic measurements of enzyme 
activity when the enzyme is bound to the surface of S. cerevisiae (provided the reaction produces 
a fluorescent product 36). The hits can be retrieved by a precise laser extraction system 31, 36. Colin 
et al. used a metagenomic library of 1.25 x 106 variants, pooled from different sources, and 
expressed in E. coli  with hopes of identifying promiscuous enzyme activity 37. Single bacterial 
cells were encapsulated into picoliter water-in-oil droplets, each presumed to contain one 
bacterial cell with a different library member, and incubated with substrate and lysis agents. After 
single cell lysis, the emulsion droplet was re-inserted into a microfluidic sorting chip, and diverted 
based on fluorescence intensity of a leaving group 31, 37. 
Semi-rational design principles discussed were applied by Pavlova et al. to develop an 
enzyme to break down the recalcitrant toxin 1,2,3-trichloropropane (TCP) 38. TCP is a byproduct 
in the manufacture of chlorinated compounds, it is used as a solvent, a component of paint and 
varnish remover, and is proposed to be a human carcinogen 39. TCP can be converted to 2,3-
dichloropropane-1-ol (DCL) by the haloalkane dehalogenase DhaA from Rhodococcus 
rhodochrous, though the rate of this reaction is too modest to support a viable remediation 
process. Random acceleration molecular dynamics (RAMD) was applied to the X-ray 
crystallographic structure of WT DhaA from R. rhodochrous to simulate the release of product, 
6 
 
the rate-limiting step, from the enzyme active site 38, 40. This simulation highlighted residues that 
might affect the movement of substrate and product through the access tunnels that connect 
the buried active site to bulk solvent to enhance conversion of TCP. Previously, two residues were 
found to increase activity 3-4 times by DNA shuffling and error-prone PCR 41. Pavlova et al., 
however, focused on further enhancement of TCP to DCL conversion with updated methods, 
including SSM to vary the nucleotide codon by more than one base pair at a time to create larger 
screening libraries. The two previous mutants were starting points for directed evolution. More 
than 5,000 clones were picked, grown, and assayed for TCP conversion using a high throughput 
colorimetric assay based on phenol red, a pH-sensitive dye. The vast majority of DhaA variants, 
96%, showed little to no improvement over WT. However, 25 clones with greater activity than 
WT were ultimately sequenced and found to have unique mutations. The steady state kinetics 
were monitored at 460 nm by mercuric thiocyanate and ferric ammonium sulfate, a more 
sensitive assay than phenol red. In the end, five mutants were generated by site-directed 
mutagenesis in the access tunnel to the active site. These mutations hindered water from getting 
to the active site as suggested by RAMD, yet increased affinity for TCP, and increased kcat 32-fold 
and kcat/KM 26-fold over the WT values. This study illustrates the utility of generating large mutant 
libraries combined with high-throughput screening for protein engineering. 
Semi-rational protein engineering and design has gained traction over the large 
combinatorial libraries of directed evolution 42. Semi-rational approaches can harbor smaller, 
functionally rich libraries of variants, and reduce the reliance on high-throughput screening.  
De novo design is the last method currently used to engineer enzymes, but it may be the 
most difficult method to execute. First, a chemically plausible transition state for the desired 
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reaction is designed, then an active site that stabilizes that transition state is erected around it 
by quantum mechanics/molecular mechanics (QM/MM) calculations 23, 43. That transition state 
and active site are then put into an existing protein scaffold and designed using a protein 
modelling software package such as ROSETTA 44, 45. This in silico/in vitro technique requires 
 
Figure 1. Enzymes have been engineered to perform the Kemp elimination (A) 1, Diels-Alder reaction (B) 3, retro-aldol 
cleavage (C) 4. Both the Kemp and Diels-Alder reactions are not found in nature. 
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structural information and is most useful for designing enzymes specifically for reactions found 
not to occur in nature to aid in synthetic organic chemistry. Examples of in silico-designed 
proteins have been more encouraging in recent years, though kinetic rates are still much slower 
than natural enzymes 46. Directed evolution performed after the de novo design has been found 
to drastically improve activity 44. Notably, the Baker laboratory has engineered enzymes in this 
way to perform the non-natural (i.e. not found in biological systems) reactions shown in Figure 
1. These include the Kemp elimination (A), the Diels-Alder reaction (B), and retro-aldol cleavage 
(C) 1, 3, 4. They were first to tackle the challenge a multistep reaction with a non-natural substrate 
4. Retro-aldol cleavage has been described as the most difficult designed enzyme to date due to 
its multistep reaction. Multistep reactions are more difficult to engineer, since multiple transition 
states and intermediates must be considered simultaneously in the design of a composite 
transition state in order for the reaction to occur 47-49. 
Three considerations were given priority for the in silico design of retro-aldol cleavage, 
borrowing themes from naturally occurring Type I aldolases: a hydrophobic pocket to lower the 
pKa of the catalytic lysine, proton transfer from an ordered water molecule, and substrate binding 
interactions 47. The three major protein scaffolds used were the jelly roll (PDB ID 1f5j), nuclear 
transport factor 2 (NTF2) (PDB ID 1oho), and triosephosphate isomerase (TIM) barrel (PDB ID 
1lbl) folds. Various positions within the active site were tested for the catalytic lysine to optimize 
the Schiff base chemistry. Rational design was first done to residues in the active site to study 
the relationship between sequence and activity. Surface residues were next altered to improve 
solubility. Once an apparent optimum had been reached as determined by steady state kinetics, 
directed evolution was done. Error prone PCR and DNA shuffling resulted in variants with 
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improved activity. In the improved variants, the mutations were found typically throughout the 
protein. The most successful mutant was a TIM barrel that acquired 11 overall amino acid 
changes concentrated largely in the active site, with a few occurring on the surface. Second shell 
and buried residues were also changed. It is proposed that these mutations led to a different 
conformation of an active site loop, as supported by lower B-factors, in the crystallographic 
structure compared to earlier models 48. A B-factor is a measurement related to the atomic 
displacement of an atom from its average position 50. Overall, the information gleaned from this 
study was the need for a flexible protein backbone rather than a rigid structure, and supporting 
functional groups throughout the protein to increase activity.  
The information gained from protein engineering can be applied to interpretation of 
other work and facilitate understanding enzymes as a whole. Subtle changes of a significant 
residue in a protein sequence can change protein activity, binding, and/or stability. Instances 
throughout history can tell the story of biocatalysts before directed evolution or de novo work 
were considered. 
1.3 Acetoacetate Decarboxylase 
Clostridium acetobutylicum is one of the first examples of an industrial, whole cell 
biocatalyst, that later became well-studied for its specific contributions to acetone, butanol, and 
ethanol production. It was in 1905 that acetone was discovered as a product of microbial 
fermentation by Schardinger, and in 1913 Chaim Weizmann discovered the anaerobic bacterium 
that would be named C. acetobutylicum 51. Weizmann began producing acetone and butanol 
from potatoes on an industrial scale in Britain, though the microbe could accept other starchy 
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substances, as well as glucose. Despite the small initial industrial process for acetone, it was not 
enough to supply the British war effort at the advent of World War I in 1914. The British Navy, of 
which Winston Churchill was a high ranking officer, heard about Weizmann and encouraged him 
to develop large-scale industrial acetone production. Acetone was needed to produce cordite, or 
smokeless gunpowder, for British munitions manufacture. Throughout World War I, the 
Weizmann process, the production of acetone, butanol, and ethanol (ABE fermenation), used C. 
acetobutylicum fermentation with maize as the original industrial starting material 52. The ABE 
process was the industrial norm until the late 1940s, when more efficient and cheaper 
petroleum-based methods were developed 51. Since green chemistry has been a larger concern 
in recent years, there is renewed interest in C. acetobutylicum for its use in production of biofuels 
53. 
There continued to be an interest in one specific enzyme that aided in the transformation 
of starch to acetone, acetoacetate decarboxylase (ADC). ADC is involved in solventogenesis, 
which begins as cell growth slows down and transitions from classical sugar fermentation to 
solvent production (acetone, butanol, and ethanol) 54. In the 1960s-70s, Frank Westheimer 
pioneered the application of physical organic chemistry principles to the study of enzymes, using 
ADC as a model. He found that the reaction took place via a Schiff base mechanism 55. 
Westheimer used a nitrophenol reporter group to propose that a perturbed pKa of an active site 
lysine was responsible for the cleavage of acetoacetate to acetone and carbon dioxide. Without 
a structure of the enzyme, he suggested the perturbed pKa was due to the electrostatic 
interaction of an adjacent base, lysine side chain (K116), shifted the pKa of the active site lysine 
(K115), from about 10 to about 6 56-58. Another study, from Highbarger et al., supported that K115 
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was the catalytic residue by chemical rescue of the active site K115 and adjacent K116 59. Residue 
115 was changed to a cysteine while K116 remained, and at pH 6.0, the optimum of WT ADC, no 
cleavage occurred for acetoacetate. However, activity was restored by aminoethylation of the of 
the mutated C115 residue, which is very nearly the same size as the original lysine residue. In 
addition, K116 was mutated to arginine, while K115 remained; the activity for K116R was lower 
than WT, however the pKa for K115 was similar to WT, presumably due to the proximity of the 
protonated arginine. Likewise, when K116C was alkylated with 2-bromoethylammonium 
bromide, activity was restored and the pKa of K115 matched that of WT 59, 60. Westheimer passed 
away in 2007, two years before the structures of acetoacetate decarboxylase from C. 
acetobutylicum (CaADC) and Chromobacterium violaceum (CvADC) were solved 5. These 
crystallographic models showed that the perturbed pKa of K115 was due to the hydrophobic 
microenvironment, and not due to the electrostatics of the active site lysine and another 
protonated base, K116, next to it, as illustrated in Figure 2 6. The largely hydrophobic active site 
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of acetoacetate decarboxylase destabilizes the protonated amine, leading to the effect observed 
by the nitrophenol reporter group. 
1.4 Acetoacetate Decarboxylase-Like Superfamily 
Nature is a master of doing more, with less. Enzymes are no exception, as a relatively 
small number of protein folds have been adapted to perform the myriad chemical reactions 
occurring in living organisms 61. It is possible to find numerous examples of putative or 
hypothetical enzymes in the genome sequence databases, and it is often assumed that the 
functions of so-called hypothetical proteins will match those of the closest homologs of known 
function. However, the versatility of enzyme scaffolds means that these assumptions are often 
wrong 17, especially when the level of sequence identity falls below 40 percent 62. The 
 
Figure 2. Schematic representation of Westheimer’s electrostatic pKa perturbation hypothesis (A). The red 
arrows represent electrostatic repulsion, and the blue arrows indicate electrostatic attraction. The 2009 
structurally supported hydrophobic environment illustrates the proximity of Arg29 to orient the carboxylate 
group in plane with the subsequent imine (B) 5, 6. 
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acetoacetate decarboxylase-like superfamily (ADCSF; IPR010451, IPR023375, and IPR023653) is 
a prime example of this 2. This superfamily contains about 2,000 enzymes, which were all 
assumed to catalyze the cleavage of acetoacetate to acetone and carbon dioxide. Although this 
conversion does appear to dominate the superfamily, it has been shown that there is significant 
chemical diversity within the ADCSF 2, 63. There are too many sequences in even a small 
superfamily like the ADCSF to clearly see the relationships between them, so protein sequence 
similarity networks (SSN) were designed to visualize these large protein sequence data sets 18. 
The aim of the Enzyme Function Initiative-Enzyme Similarity Tool (EFI-EST) is to separate 
superfamilies into isofunctional clusters based on overall sequence similarity, and to shed light 
on uncharacterized enzymes by observing their positions relative to well characterized ones. 
SSNs are determined via BLAST scores; they are more visually impactful than dendrograms and 
trees, which need computationally intense work for rigorous sequence alignments for large 
groups of sequences. The sequence similarity network for the ADCSF calculated at e = 10-10 is 
 
Figure 3. Sequence similarity network for ADCSF calculated with an e value cutoff of 10-10. The clusters are based on manual 
investigation of active site residues of a limited number of active site sequences. 
14 
 
shown in Figure 3. The sizes of the nodes (red dots) reflect sequence length, and the edges (lines 
connecting the nodes) are colored according to sequence identity, with red corresponding to 0 
percent identity, and purple to 100 percent. All of the sequences from Family V are more similar 
to each other than any other sequences in the diagram of Figure 3. 
 The first Family V 
enzyme to be studied was 
Mannopeptimycin R 
(MppR), an enzyme involved 
in the biosynthesis of the 
non-proteinogenic amino 
acid L-enduracididine, a necessary component of the antibiotics mannopeptimycin and 
enduracidin, both of which are effective against methicillin resistant staphylococcus aureus 
(MRSA).  
 
Figure 4. The role of MppR in L-Enduricididine production. 
 
 
Figure 5. Aldolase-dehydratase reaction catalyzed by MppR. 
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MppR from S. 
hygroscopicus (ShMppR) 
was observed in X-ray 
diﬀraction experiments 
to catalyze the cyclization 
of 2-oxo-4-hydroxy-5-
guanidinovaleric acid (i.e., 
“4-hydroxy-
ketoarginine”) to give what would become, after hydrolysis from the enzyme, the keto form of 
the nonproteinogenic amino acid enduracididine, (Figure 4) 2. MppR is proposed to take a highly 
oxidized arginine derivative and dehydrate the gamma hydroxyl to a double bond, before 
catalyzing the attack of a guanidinium nitrogen 
on the gamma carbon, to give the final 
iminoimidizolidine ring product (Figure 4) 2. 
However, it can also catalyze the aldol 
condensation of pyruvate and imidazole-4-
carboxaldehyde, (Figure 5). ShMppR functions 
via a mechanism that includes a Schiff base 
intermediate. This is similar to the Type I 
aldolases, which also use a lysine Schiff base in 
their mechanisms. Interestingly, all known 
Type I aldolases possess the TIM barrel fold. It 
 
Figure 6. The quaternary structure comparison of MppR (Family V) and CaADC (Family 
I). PDB IDs are 4JM32 and 3BH25, respectively. 
 
 
Figure 7. The fold of MppR is almost identical to that of 
ADC, rather than the TIM barrel fold, associated with Type 
I aldolases. 
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is not known if whether this is just the way evolution occurred, or if there is something unique 
about the TIM barrel that suits it for the aldolase reaction. 
Although MppR is a tetramer and ADC is a homododecamer, there does not appear to be 
any functional significance to the quaternary structure. Despite the MppR protomer being almost 
identical to ADC, MppR does not perform any decarboxylation like that of typical ADCs 2. Subtle 
differences in the active site are responsible for this. The adjacent glutamate in the active site, 
responsible for decarboxylase activity in CvADC 5, has been replaced with valine in MppR 2. In 
addition, the arginine responsible for orienting the carboxylate group of acetoacetate in CvADC 
is occupied by the indole ring of tryptophan in MppR.  
 
Figure 8. Sequence alignment excerpt comparing Family I and Family V (shaded blue). 
17 
 
Two hydrophobic residues in the active site of CvADC are polar in MppR, making a carboxylate 
subsite to bind α-keto acids (Figures 4 and 5).  
An examination of multiple sequence alignments aids in explaining these differences in 
catalytic ability. The RxxxQ/N motif in Family V is not found in the Family I decarboxylases, and 
may indicate other members of the family. There are two key residues conserved between the 
two families, the lysine-glutamate catalytic dyad. The active site lysine and the likely glutamate 
acid/base catalyst are highlighted in purple in Figure 8. They are within hydrogen bonding 
distance of each other in the active site. Although this pair of residues and others are conserved, 
the residues responsible for decarboxylation are not retained in Family V. The arginine in Family 
I that aids in orienting the acetoacetate for nucleophilic attack (red box) is not conserved in 
Family V. Likewise, the glutamate that facilitates decarboxylation in Family I (red box) has 
different residues in Family V. The differences in these two key decarboxylase residues explains 
why MppR is not a decarboxylase, though the conservation of the active site lysine and glutamate 
hints that activity may still occur through a Schiff base mechanism. 
Family V of the ADCSF is comprised of enzymes predicted to be involved in secondary 
metabolism, including the biosynthesis of antibiotics and the catabolism of aromatic 
hydrocarbons. To learn more about the diversity of chemistries performed in this family, we have 
been studying Sbi_00515 from Streptomyces bingchenggensis (SbAD) and Swit_4259 from 
Sphingomonas wittichii (Swit). Kinetic analyses of these enzymes demonstrate that neither 
decarboxylates acetoacetate or similar compounds. X-ray crystallography revealed that, although 
the quaternary structures are different, the overall folds of Sbi_00515 and Swit_4259 are almost 
indistinguishable from that of ADC, like with MppR. 
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Sbi_00515 catalyzes the aldol condensation and subsequent dehydration of pyruvate with 
a variety of aldehydes. It is quite specific for pyruvate, but reacts with a surprising number of 
unsaturated, aliphatic and aromatic aldehydes. I performed the protein purification, site-directed 
mutagenesis, and both steady state and transient kinetics on Sbi_00515 in order to determine 
the substrate specificity profile and develop a plausible mechanism. The kinetic work was 
supported by my X-ray crystallography, HPLC, and NMR work. I also performed single turnover 
kinetics and kinetic isotope effect experiments to further develop our initial mechanistic 
hypothesis. As it stands, our mechanism has the enzyme reacting with pyruvate to form a Schiff 
base, after which the nucleophilic enamine attacks the aldehyde’s electrophilic carbonyl to form 
a new carbon-carbon bond. Details of the dehydration step are still unclear, but may involve 
substrate-assisted catalysis. The Schiff base with product is hydrolyzed to regenerate the enzyme. 
Although the biological function of Sbi_00515 is unknown, it may synthesize a non-canonical 
starter or extender unit of a nearby uncharacterized secondary metabolite biosynthesis cluster. 
Streptomyces bingchenggensis, the organism that produces Sbi_00515, is not available. 
Fortunately, there is a homolog from Burkholderia terrae, WQE_44883 (85% sequence identity), 
which will be used to investigate the enzyme’s physiological role. The first step in this endeavor 
is to find the growth conditions under which the gene is expressed. Metabolomics experiments 
in the Shimazdu Lab for Advanced and Applied Analytical Chemistry at University of WI-
Milwaukee may then be able to highlight molecules that are only produced when Sbi_00515 is 
expressed. 
Swit_4259 is able to catalyze the aldol condensation with pyruvate and a limited range of 
aldehyde substrates, however it is orders of magnitude slower than Sbi_00515. It is much more 
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efficient catalyzing the hydration of unsaturated α-keto acids without retro-aldol cleavage. Its 
physiological function is also unknown, however, based on gene context, Swit_4259 is proposed 
to contribute to the degradation of aromatic hydrocarbons.  
All of my work shows that Sbi_00515 and Swit_4259 are the first Schiff base forming 
aldolases that do not possess a TIM barrel fold. Although the tertiary structures are almost 
identical, these two enzymes exhibit different activities, likely due to subtle changes in the active 
site architecture. The significance of these enzymes is that they are the first evidence that the 
ADC fold is a versatile platform that can be adapted to perform different chemistries, expanding 
the knowledge of protein catalysis, and making these enzymes potential candidates for future 
protein engineering experiments. 
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CHAPTER II: STRUCTURAL CHARACTERIZATION OF SbAD 
2.1: Introduction 
 Analysis of MppR (mannopeptimycin R) from the acetoacetate decarboxylase-like 
superfamily (ADCSF) gave the first indication that this superfamily may contain enzymes that 
catalyze diverse reactions, and as such, is a potential source of useful biocatalysts 1. Based on 
gene context, it is proposed that the MppR-like enzymes, Family V of the ADCSF, are involved in 
production of secondary metabolites. A BLAST search with MppR sequence returned a protein 
from a bacterial genome noted for its secondary metabolites: Sbi_00515 from Streptomyces 
binchenggensis BCW-1. The Gram-positive S. bingchenggensis has one of the largest genomes 
sequenced to date at about 12 million bp 2. Much of the S. bingchenggensis genome is devoted 
to production of secondary metabolites. S. bingchenggensis contains at least 47 gene clusters 
linked to biosynthesis of identified or anticipated secondary metabolites 3. These include 
milbemycins A3 and A4 that are used extensively to control parasitic worms in animals, 10 
additional milbemycin analogues, the polyether antibiotic nanchangmycin, the antitumor agents 
bingchamide A and B, and at least 23 uncharacterized nonribosomal peptide, polyketide, or 
terpene biosynthetic clusters 2-8. Sbi_00515 is currently annotated as an acetoacetate 
decarboxylase, yet like MppR, it is missing the same key arginine and glutamate residues 
responsible for decarboxylase activity in the ADCs, and is located near an uncharacterized 
polyketide biosynthetic cluster 2.  
 Sbi_00515 has 39% sequence identity to MppR from Streptomyces hygroscopicus 
(ShMppR), and 265 amino acids 9. Based on sequence alignment to ShMppR, Sbi_00515 is likely 
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to have the same carboxylate binding site and lack of decarboxylase activity. Although both 
Family V enzymes retain the key lysine and likely acid/base catalyst glutamate that can form a 
Schiff base intermediate, it is possible that Sbi_00515 may not act in the same manner as MppR. 
Sequence alignment comparing the active site residues of MppR with Sbi_00515 shows that in 
two positions where MppR has Phe, Sbi_00515 has Tyr, and Glu in MppR is replaced with another 
Tyr in Sbi_00515. The change in residues of the likely active site of Sbi_00515 could influence 
substrate specificity or reaction(s) catalyzed. The S. bingchenggensis bacterium is not available 
for biological study due to intellectual property concerns, therefore its physiological activity will 
likely never be known. Therefore, the purpose of this study was to investigate the catalytic 
capacity of the MppR-like family specifically, and the ADCSF in general. 
 
2.2 Materials and Methods 
Cloning, Expression, and Purification of Sbi_00515.  
The coding sequence of Sbi_00515 was optimized for expression in Escherichia coli and 
synthesized by GenScript Inc. (Piscataway, NJ). This synthetic gene was subcloned into the pE-
SUMOkan expression vector (LifeSensors Inc., Malvern, PA) using primers containing BsaI and XbaI 
restriction sites (forward, 5′-GGTCTCAAGGTATGAAAGGTTATACGGTTCCG-3′; reverse, 5′-
GCTCTAGATCATCATGCCGAATGGTCTGC-3′). The His6-tagged SUMO−Sbi00515 fusion protein was 
expressed from E. coli BL21 Star (DE3) cells (Invitrogen Inc., Carlsbad, CA) carrying the pE-SUMO-
Sbi_00515 plasmid. Cultures were grown in Luria-Bertani medium with 50 μg/mL kanamycin at 
37 °C. At an OD600 of about 0.9, protein expression was induced with 0.4mM IPTG. The 
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temperature was reduced to 25 °C, and the cultures were grown overnight while being shaken at 
250 rpm. Cells were harvested by centrifugation at 13000 x g, resuspended in 5 mL/g of buffer A 
[25 mM Tris (pH 8.0), 300 mM NaCl, and 10 mM imidazole] supplemented with 1 mg/mL hen egg 
lysozyme (Hampton Research) and frozen at −20 °C. Cells were lysed by thawing the resuspended 
cells for 2 hours at room temperature (RT), after which DNase I (Worthington Biochemical Corp., 
Lake-wood, NJ) was added to achieve a concentration of 0.1 mg/ml. The lysate was clarified by 
centrifugation at 39000 x g for 45 min and then applied to a 5 mL HisTrap column (GE 
Lifesciences,Piscataway, NJ) at a flow rate of 5 mL/min to isolate the His6-SUMO−Sbi_00515 
fusion protein. The protein was eluted by a four-step gradient of buffer B [25 mM Tris (pH 8.0), 
300 mM NaCl, and 250 mM imidazole (5, 15, 50, and 100%)]. The His6-SUMO−Sbi_00515 fusion 
protein eluted in the third and fourth steps and was ∼90% pure, as judged on Coomassie-stained 
sodium dodecyl sulfate−polyacrylamide gel electrophoresis (SDS-PAGE) gels. Peak fractions were 
pooled and dialyzed overnight against 3.5 L of 25 mM Tris (pH 8.0) and 150 mM NaCl in the 
presence of about 3 μM SUMOprotease (LifeSensors Inc.). The dialysate was passed through the 
HisTrap column a second time to remove the cleaved His6-SUMO tag as well as the protease. The 
resulting Sbi_00515 preparation was >95% pure. Selenomethionine-labed Sbi_00515 was 
purified using the same protocol, except that SelenoMethionine Medium Complete (Molecular 
Dimensions, Newmarket, Suffolk, U.K.) was used as the growth medium rather than Luria-Bertani 
broth and T7 Express Crystal cells (New England Biolabs, Ipswich, MA) were used in place of the 
BL21 Star (DE3) cells. 
Crystallization, Structure Determination, and Model Refinement.  
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Initial crystallization conditions were identified by screening 45 mg/mL Sbi_00515 against 
the Index HT screen (Hampton Research). After optimization, diffraction-quality crystals were 
obtained by the hanging drop vapor diffusion method from 3.5−3.7 M potassium formate, 2−3% 
polyethylene glycol monomethyl ether 2000 (PEG MME 2k), and 100 mM BIS-Tris propane (pH 
9.0). Drops contained 1−2 μL of a protein solution at 45 mg/mL and 1 μL of a crystallization 
solution. Crystals formed as plates that appeared after 3−4 days and grew to maximal dimensions 
of about 800 μm × 200 μm × 50 μm. Crystals of selenomethionine (SeMet)-substituted Sbi_00515 
were grown using the same conditions. Crystals were cryoprotected with Paratone N (Hampton 
Research) and flashed-cooled by being plunged into liquid nitrogen. The structure of Sbi_00515 
with pyruvate bound was obtained by transferring crystals of native Sbi00515 into 30 μL drops of 
a soaking solution containing 4.0M potassium formate, 3% PEG MME 2k, 100 mM BIS-Tris 
propane (pH 9.0), and 30 mM sodium pyruvate. After soaking overnight, crystals were treated 
with Paratone N and flash-cooled. X-ray diffraction data for SeMet Sbi_00515 and a higher-
resolution native data set were collected at beamline 21-ID-D of the Life Science Collaborative 
Access Team (LS-CAT) at the Advanced Photon Source (APS). The Sbi_00515·pyruvate data set 
was collected using the rotating anode X-ray source at Marquette University. Data were 
processed with HKL2000 or MOSFLM and SCALA of the CCP4 Program Suite 10-14. The structure of 
Sbi_00515 was determined by the single-wavelength anomalous diffraction (SAD) method using 
1.9 Å-resolution data collected from a crystal of SeMet-substituted Sbi_00515 at 0.97921 Å, 4.0 
eV above the tabulated K-edge wavelength for Se (0.97950 Å). The program autoSHARP was used 
to determine the Se substructure, which contained 16 of the 24 Se atoms in the asymmetric unit, 
and to calculate density-modified electron density maps. An initial model comprising about 75% 
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of the asymmetric unit contents was built automatically using the PHENIX package 
(phenix.autobuild) 15-17. After iterative cycles of manual model building in COOT and maximum 
likelihood-based refinement using the PHENIX package (phenix.refine), ordered solvent 
molecules were added automatically in phenix.refine and culled manually in COOT 18, 19. 
Hydrogen atoms were added to the model using phenix.reduce and were included in the later 
stages of refinement to improve the stereochemistry of the model 20. Positions of H atoms were 
refined using the riding model with a global B factor. Regions of the model for translation-
libration-screw (TLS) refinement were identified using phenix.find_tls_groups, and the TLS 
parameters were refined in phenix.refine. Once the refinement converged (e.g., for SeMet 
Sbi00515, R = 0.162 and Rfree = 0.185), the model was validated using the tools implemented in 
COOT and PHENIX 21, 22. Sections of the backbone with missing or uninterpretable electron 
density were not included in the final model. Side chains with poor or missing electron density 
were modeled in favored rotameric conformations. The B factors were allowed to refine without 
additional restraints, and the occupancies for atoms in all residues without alternate 
conformations were constrained to be 1.0. 
The final, refined model of SeMet Sbi_00515, stripped of water molecules and H atoms, 
and with all B factors set to 20.0 Å2, was used to determine the structures of Sbi_00515 
“unliganded” (with formate bound) and with pyruvate bound by the difference Fourier method. 
A similar refinement protocol was used for both models presented here. In the case of the 
Sbi_00515·pyruvate structure, restraints for the link between Lys122 and pyruvate were 
generated with phenix.elbow 23. Data collection and model refinement statistics are listed in 
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Table 2.1. Coordinates and structure factors have been deposited in the Protein Data Bank as 
entries 4ZBO and 4ZBT. 
2.3 Results and Discussion 
Overall Structure and Comparisons to CaADC and ShMppR. 
 Figure 9. (A) Rendering of the 
solvent-accessible surface of 
Sbi00515 showing the extensive 
tetramer interface formed by the 
long, interdigitating loops (top). This 
interface is repeated on the back 
side with the orange and pale yellow 
protomers. The pair of dimers is held 
together (bottom) by short loops 
that appear to “clip” the two dimers 
together to form the tetramer. (B) 
The ribbon diagram showing a single 
protomer is oriented like the dark 
blue protomer in panel A. The main 
barrel of the β-cone fold is colored 
pale blue, with the “side barrel” 
colored green. The dimer interface 
loops are colored yellow, and the 
loops forming the interface between 
the dimers are colored orange. The 
section of the polypeptide that is 
colored red is the “active site loop” 
that may control access to the active 
site. The catalytic Lys122 is shown as 
a ball-and-stick representation with 
purple carbon atoms. 
 
Sbi_00515 has a protomer weight is 28,145 Da and, like MppR, was shown to be 
tetrameric in solution using size exclusion chromatography. Sbi_00515 crystallized in space group 
P21212 with four molecules in the asymmetric unit (unit cell dimensions a = 157.3Å, b = 123.5 Å, 
c = 53.1 Å, and α = β = γ =90°). The asymmetric unit contents are arranged in a tetramer that 
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matches closely the arrangement seen in ShMppR 1. This tetramer is a dimer of dimers (Figure 9 
A). The “dimer interface” is extensive, being comprised of interdigitating loops (Met1−Pro21 and 
Arg186−Glu203; yellow in Figure 9 B) that bury 2642 Å2, or 20% of the protomer surface area. 
The interface between the dimers, which we call the “tetramer interface”, is smaller, burying 
1621 Å2, or 12% of the protomer surface, and is also comprised of two surface loops (Ser68−Gln81 
and Gln129−Gly164; orange in Figure 9 B). The homotetrameric quaternary structure shared by 
Sbi_00515 and ShMppR is markedly different from that of CaADC, which is a homododecamer.  
Table 1. Crystallographic Data Collection and Model Refinement Statistics. 
 
 SeMet Sbi_00515 native Sbi_00515 Sbi_00515·pyruvate 
    
resolution (Å) (last shell)a 46.5−1.9 (1.97−1.90) 41.58−1.4 (1.45−1.40) 39.9−1.8 (1.86−1.80) 
wavelength (Å) 0.97921 0.97896 1.54180  
no. of reﬂections 
             observed 
             unique 
 
1131019 (96476) 
82988 (8183)  
 
1626413 (91229) 
207128 (20393) 
 
285228 (8521) 
92300 (6104) 
completeness (%)a 100.0 (100.0) 99.9 (99.5)  95.4 (64.0) 
Rmerge (%)a,b 0.145 (0.456) 0.071 (0.560) 0.102 (0.334) 
multiplicity 13.6 (11.8) 7.9 (4.5) 3.1 (1.4) 
⟨I/σ(I)⟩a 22.3 (5.9) 20.5 (2.2)  12.3 (1.7) 
ﬁgure of merit (acentric) 0.283   
phasing power 1.102   
Model Refinement 
    
no. of reﬂections in the work set 78722 207021 92221 
no. of reﬂections in the test set 4185 2960  4631 
Rcryst (Rfree) 0.162 (0.185) 0.154 (0.176)  0.163 (0.205)  
no. of residues 1023 1034 1028 
no. of solvent atoms 1166 1385 1289 
no. of TLS groups 24 25 25 
average B factor (Å2)c 
               protein atoms 
               ligand atoms 
               solvent 
 
15.9 
35.6  
26.9 
 
21.0 
33.9 
34.1  
 
21.4 
31.9 
31.3 
root-mean-square deviation 
               bond lengths (Å) 
               bond angles (deg) 
               coordinate error (Å) 
 
0.005 
0.979 
0.30 
 
0.009 
1.303 
0.12 
 
0.011 
1.309 
0.18 
Ramachandran statistics 
(favored/allowed/outliers) 
 
98.2/1.8/0 
 
97.7/2.3/0  
 
97.2/2.8/0 
 
aValues in parentheses apply to the high-resolution shell indicated in the resolution row.  
bR = ∑(||Fobs| − scale ×| Fcalc||)/∑|Fobs|. cIsotropic equivalent B factors, including the contribution from TLS reﬁnement. 
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Figure 10. (A) Stereoview of the active site in the “unliganded” Sbi_00515 structure showing potassium formate from the 
crystallization solution bound (refer to Figure 11 for relevant hydrogen bonding interactions and their distances). The position 
of this formate ion shows that the carboxylate-binding site identified in S. hygroscopicus MppR is retained in Sbi_00515. The 
lower water molecule in this view (labeled “1” in Figure 11) bridges Tyr82 and Glu84, suggesting that both residues could 
participate in the Schiff base chemistry. The upper water molecule (“2” in Figure 11) is held in place by interactions with 
Tyr252, which is the major difference between the Sbi_00515 and ShMppR active sites. (B) The Sbi_00515·pyruvate Schiff base 
complex shows pyruvate covalently bound to the enzyme as indicated by continuous electron density between Lys122 and 
the α-carbon of pyruvate. The side chain of pyruvate is too short to unequivocally differentiate between the imine and 
enamine forms of the Schiff base. Note that water “1” has been displaced, water “2” remains in a similar position, and two 
new water molecules have been recruited so that Glu84, Gln118, and Tyr252 are all linked by an extensive hydrogen bonding 
network. In both panels, the experimental 2|Fo|−|Fc| electron density map (magenta) and the simulated annealing composite 
omit 2|Fo| − |Fc| electron density map (green), both contoured at 1.0σ, are drawn with a 2.0 Å radius around each atom of 
Lys122, formate or pyruvate, and select water molecules. This figure and subsequent figures showing crystallographic 
structures were rendered with the POVSCRIPT+24 modification of MOLSCRIPT25 and POVRAY. 
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In both Sbi_00515 and ShMppR, the trimerization platform of CaADC is occluded by the loops of 
the tetramer interface. This pair of sequence insertions accounts for the difference in quaternary 
structures between the classical ADCs and the MppR-like family. Thus far, there is no known 
functional consequence of the quaternary structure in ADCSF enzymes. 
The tertiary structure of Sbi_00515 is essentially identical to those of both MppR and 
CaADC, with root-mean-square deviations (RMSDs) for all aligned Cα atoms of 1.4 and 1.7 Å, 
respectively. This is not surprising, given that all ADCSF proteins of known structure {PDB entries 
3BH2, 3BH326, 4JM31, 3C8W [Joint Center for Structural Genomics (JCSG), unpublished], and 
3CMB (JCSG, unpublished)} share the same β-cone or double-barrel fold first identified by Ho et 
al.26 (Figure 9 B). In spite of the remarkable similarity of the overall folds, the active sites of 
Sbi_00515 and CaADC are different. Specifically, as in ShMppR, Arg29, the residue responsible 
  
Figure 11. Schematic views of (A) the Sbi_00515·formate complex and (B) the Sbi_00515·pyruvate complex showing potential 
hydrogen bonding interactions and their distances (in Angstroms). 
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for orienting the substrate in CaADC, and Glu61, thought to electrostatically encourage the 
carboxylate group of acetoacetate to leave as CO2, are missing in Sbi_00515. These two sequence 
changes alone would account for the loss of acetoacetate decarboxylase activity in the MppR-
like enzymes. 
The other major difference between CaADC and the MppR-like enzymes is the presence 
of the very polar “carboxylate-binding site” adjacent to the catalytic lysine residue (Lys122 in 
Sbi_00515). This site is marked in the “unliganded” structure of Sbi_00515 by a bound formate 
ion from the crystallization solution (Figures 10 A and 11 A). The ion is held by hydrogen bonding 
interactions between O1 of formate and the hydroxyl group of Tyr24 (2.6 Å) or the guanidinium 
group of Arg114 (2.7 Å), and between O2 of formate and the amide nitrogen atom of Gln118 (2.9 
Å) or the amino group of Lys122 (2.7 Å). Two water molecules are also bound in close proximity 
to the catalytic Lys122 and the bound formate ion. One, labeled “1” in Figure 11 A, is bridging 
Tyr82 and Glu84 (equidistant at 2.7 Å), while the other, labeled “2,” is held by interactions to 
water “1” (2.9 Å) and the hydroxyl group of Tyr252 (2.6 Å). The position of water molecule “1,” 
only 3.3 Å from the amino group of Lys122, suggests that Tyr82 and Glu84 might both participate 
in the Schiff base chemistry of Lys122. 
The active site of Sbi_00515 is similar to ShMppR, however a few changes in residues 
appears to alter the substrate specificity and reactivity of catalysis 1. In Sbi_00515, Tyr252 
replaces the Glu283 of MppR that is thought to help orient the guanidinium group of a 
hydroxylated arginine derivative for cyclization 1. In addition, Tyr82 is a phenylalanine residue in 
MppR (Phe116), and Tyr24 of Sbi_00515 is also a phenylalanine in ShMppR (Phe58). All of the 
other residues are identical (Figure 12 A). Tyr24 of Sbi_00515 is especially interesting, because it 
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is a component of the carboxylate-binding site not present in ShMppR and alters the 
conformation of the Schiff base complex between pyruvate and Lys122. 
 
Schiff Base Complex with Pyruvate.  
Crystals of Sbi_00515 were soaked in a solution containing 30 mM sodium pyruvate, and 
the resulting covalent enamine/imine complex was trapped crystallographically (Figures 11 B and 
12 B). The carboxylate moiety of pyruvate is bound in the carboxylate-binding site of the enzyme, 
making hydrogen bonding interactions with the hydroxyl groups of Tyr24 and Tyr82 (2.6 and 3.2 
Å, respectively) and the amide nitrogen atom of Gln118 (2.8 Å), as well as a potential salt bridge 
with Arg114 (bidentate at 3.0 Å). Binding of pyruvate does not impact the positions of the side 
chains comprising the carboxylate-binding site [Tyr24, Arg114, and Gln118 (Figure 12 A)], 
indicating that this site is preconfigured to bind α-keto acids. This may explain why the Schiff base 
complex is sufficiently stable to be observed in the crystal structure. The residues closer to the 
catalytic center, Tyr82, Glu84, and Val106, experience small, but significant and concerted, 
changes in their positions. Tyr82 swings toward the catalytic lysine, moving the hydroxyl group 
by 0.6 Å, while Glu84 swings away from Lys122, shifting its carboxylate group by 1.4 Å. The 
distance between the nearest carboxylate O atom of Glu84 and the pyruvate methyl group is 3.9 
Å. Given this arrangement, it is plausible to suggest that Glu84 might act as a general base catalyst 
to promote formation of the reactive enamine form of the Schiff base. Lastly, although it is some 
distance from the Lys122-Glu84 dyad, Tyr252 also experiences a 0.6 Å shift of its hydroxyl group 
toward Lys122, likely because of a rearrangement of the water structure around the catalytic  
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center that occurs upon formation of the Schiff base (Figure 12 B). In the pyruvate-bound 
structure, the water bridging Tyr82 and Glu84 is displaced (water “1” in Figure 11 A) and two 
 
Figure 12. (A) Stereoview showing the complex of Sbi00515 and formate (pale blue model with purple formate ion) overlaid 
on the enzyme with pyruvate bound (dark blue model). Note the subtle changes in position that occur for residues Tyr82, 
Glu84, and Tyr252, while the residues comprising the carboxylate-binding site are essentially unperturbed. (B) MppR·pyruvate 
complex (green model) overlaid on the Sbi_00515·pyruvate complex (dark blue model). In spite of the high degree of structural 
similarity (1.7 Å rmsd for all aligned Cα atoms), the arrangement of residues in the carboxylate-binding site is subtly different 
because of the addition of Tyr24 in Sbi_00515. This change results in Sbi_00515 binding the pyruvate carboxylate with a 
monodentate interaction with Arg114 and an additional hydrogen bonding interaction with Tyr24, which holds the carboxylate 
in plane with the pyruvate methyl group (2.8 Å fromCH3 to carboxylate O). This change, coupled with the Glu→Tyr change at 
position 283/252, may account, in part, for the difference in catalytic activity between Sbi_00515 and MppR. 
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additional water molecules are recruited (labeled “3” and “4” in Figure 12 B) that create a chain 
connecting Glu84, Gln118, and Tyr252. The position of water molecule “2” moves along with 
Tyr252 by 0.8 Å, placing it 3.6 Å from the pyruvate methyl group. The position of this water is 
instructive, because when the incoming aldehyde substrate is placed so that the aldehyde O atom 
overlays water “2” and the re face of the carbonyl faces the pyruvate methyl group, the distance 
between the methyl and carbonyl carbons is approximately 3 Å. 
It was somewhat surprising to find that although pyruvate occupies the same binding site 
in Sbi_00515 and ShMppR, the conformations of the Schiff base complexes are different. In 
ShMppR (PDB entry 4JMC), the pyruvate carboxylate group is nearly coplanar with the 
guanidinium of Arg148, making a clear salt bridge interaction. In Sbi_00515, the substitution of 
Tyr24 for Phe58 of ShMppR results in the carboxylate-binding site Arg and Gln residues taking 
different conformations. As a result, the pyruvate carboxylate in the Sbi_00515·pyruvate 
complex is rotated by about 30° relative to the ShMppR·pyruvate structure. The rotation of the 
carboxylate weakens or eliminates the salt bridge to Arg114 and creates a new interaction with 
Tyr24. This change also forces the carboxylate to nearly eclipse the methyl group (O2−C1−C2−C3 
torsion angle of 14°). While it is possible that this nearly eclipsed conformation just happens to 
be the lowest-energy conformation in this complex, the strain inherent in this arrangement, the 
2.8 Å distance between the carboxylate oxygen and the methyl carbon, and the potential loss of 
the salt bridge raise the possibility of substrate-assisted catalysis. It is possible that the 
carboxylate could abstract a proton from the former pyruvate methyl carbon during the 
transition from the presumed aldol intermediate to the unsaturated product. A substrate 
carboxylate is proposed to act as a general acid/base catalyst in sialic acid aldolase 27. Sialic acid 
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aldolase is specific for pyruvate, and aldol condensation occurs between pyruvate, which acts as 
a proton donor and various aldehydes. The product of the condensation reaction is determined 
by the aldehyde acceptor, as sialic acid aldolase appears to lack strict stereochemical specificity, 
unlike most Type I aldolases 27, 28. Despite the pyruvate specificity and enzymatic reversibility, a 
number of crystal structure illustrate that there are no acidic or basic residues near the reaction 
center, leading to the hypothesis that substrate-assisted catalysis must occur, as seen in Figure 
13. 27, 29, 30. In addition to sialic acid aldolase, other enzymes are thought to function with 
assistance from a substrate carboxylate as a general acid/base catalyst, such as trans-o-
hydroxybenzylidenepyruvate hydratase-aldolase and D-4-deoxy-5-oxoglucarate dehydratase 31-
33. 
 
 
Figure 13. (A) Sialic acid proposed mechanism 27, 30. 
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2.4 Conclusions  
The structures of the enzyme in complexes with formate and pyruvate point out possible 
roles of several active site amino acids. Both Tyr82 and Glu84 are near enough to the catalytic 
lysine residue to make contacts with the presumed hemiaminal intermediate during formation 
and breakdown of the Schiff base. Because only Glu84 is in a position to reach both Lys122 and 
the methyl group of pyruvate, and Tyr82 is not absolutely conserved in MppR-like enzymes, 
Glu84 is the most likely candidate for the general acid/base catalyst. The position of the water 
molecule held by Y252 in the presence and absence of pyruvate implies that this residue might 
orient the incoming aldehyde substrate for attack by the enamine nucleophile. Kinetic and 
structural characterizations of said active site residues and others are mutated in the following 
chapters to explore their effects on binding and catalysis. 
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CHAPTER III: IDENTIFICATION OF THE REACTION CATALYZED 
3.1 Introduction 
Previous studies have shown that, while ADCSF enzymes appear to be structurally 
homogeneous [e.g., CaADC (PDB entry 3BH2), Chromobacterium violaceum ADC (PDB entry 
3BH3), Legionella pneumophila ADC (PDB entry 3C8W), Methanoculleus marisnigri ADC (PDB 
entry 3CMB), Streptomyces hygroscopicus MppR (PDB entry 4JM3), and Sbi_00515 (PDB entry 
4ZBO, this study)], there is some diversity in terms of the substrates used and the chemistry 
catalyzed by members of this superfamily 1. MppR from S. hygroscopicus (ShMppR), for instance, 
can catalyze the cyclization of 2-oxo-4-hydroxy-5-guanidinovaleric acid (“4-hydroxy-
ketoarginine”) as observed by X-ray crystallography 1. After hydrolysis from the enzyme, the 
compound is the keto form of the nonproteinogenic amino acid enduracididine. While the precise 
role of ShMppR in the biosynthesis of enduracididine remains unclear, it is apparent that very 
little is known about the degree of substrate and reaction diversity within the ADCSF. 
Not surprisingly, the divergence of ShMppR and Sbi_00515’s catalytic activities from the 
classical acetoacetate decarboxylases like CaADC is associated with a number of amino acid 
substitutions in the active site. Chief among these are the loss of an Arg side chain proposed to 
orient the substrate for decarboxylation in CaADC, loss of the “second Glu” side chain thought to 
promote decarboxylation in CaADC, and an increase in polarity in the neighborhood of the 
catalytic Lys in ShMppR and Sbi_00515 2, 3. This latter change results in the formation of an α-
carboxylate-binding site 1. Comparative genome analysis of ShMppR and Sbi_00515 and closely 
related homologues showed that there exists a subset of ADCSF enzymes that share this same 
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pattern of amino acid substitutions in their putative active sites. These so-called MppR-like 
enzymes comprise one of seven sequence clusters or families within the ADCSF (Family V, Figure 
3). 
Sbi_00515 was chosen for study on the basis of its sequence similarity to ShMppR (39% 
sequence identity) and its gene context, which suggests a potential role in an uncharacterized 
polyketide biosynthetic cluster (Figure 14). 
It is predicted that the polyketide 
biosynthetic cluster produces a compound 
relevant as an anti-tumor compound, BE-
14106 (Figure 15) 4. Attempts to obtain 
samples of live cells or genomic DNA were unsuccessful because of intellectual property 
concerns. As such, the precise biological function of Sbi_00515 cannot currently be veriﬁed. 
Although Sbi_00515 and ShMppR have both been shown by X-ray crystallography to bind 
pyruvate, the carboxylate group of pyruvate is bound in different conformations in each enzyme 
 
Figure 14. Gene content of Sbi_00515, in red as 515. The bubbles are annotations from the NCBI database. Often in bacteria, 
genes for a process are located near one another, with the Type I polyketide synthase (522/PKS2) in purple of primary interest. 
 
Figure 15. BE-14106, the predicted product of Type I polyketide 
synthase (522/PKS2) of Figure 14. 
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3. Other subtle active site differences between ShMppR and Sbi_00515 result in different 
positions for conserved waters. This hints that Sbi_00515 and ShMppR may not have the same 
activities, despite the fact that both are expected to retain the Schiff base mechanism of 
acetoacetate decarboxylase based on their active site residues. 
 
3.2 Materials and Methods 
Materials 
 Aldehyde substrates and sodium pyruvate were sourced from Sigma-Aldrich. 
Cloning, Expression, and Purification of Sbi_00515.  
 The protein was previously cloned and expressed as described in Chapter II 3. 
Preparation of Benzylidenepyruvate (1). 
(E)-2-Oxo-4-phenylbut-3-enoicacid (Scheme 1, 1) was prepared by a modiﬁcation of the 
technique of Reimer 5 . A suspension of benzaldehyde (5.22 g, 49.2 mmol), sodium pyruvate (5.42 
g, 49.3 mmol), and KOH (1.41 g,25.2 mmol) in 15 mL of methanol and 15 mL of water was warmed 
from < 10 to 35 °C and held at that temperature for 1.5 hours, over which time the starting 
materials dissolved, and then the product crystallized. Filtration, rinsing with 50 mL of cold 
methanol, and drying in vacuo gave 5.25 g of a yellow solid. A solution of 5.18 g of the yellow 
solid in 150 mL of water was ﬁltered and acidiﬁed with HCl (2.0 M, 180 mL), and the resulting 
precipitate was isolated by ﬁltration and then dried by addition and rotary evaporation of 50mL 
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of toluene in vacuo to yield 2.91 g of product as an orange solid (34% yield). The 1H and 13C NMR 
spectra of this product were identical to those reported previously 6. 
Preparation of 3-(2-furyl)acrolenepyruvate (22). 
6-(furan-2-yl)-2-oxohexa-3,5-dieneoate (Scheme 4, 22) synthesis began with 0.4243 g 
(3.47 mmol) of 3-(furan-2-yl)acrylaldehyde was combined with 0.420 g (3.86 mmol) of sodium 
pyruvate and 0.1300g (3.25 mmol) of sodium hydroxide in a dry round bottom flask. Once 
combined, 50 mL of methanol was added to the reaction mixture and the flask was attached to 
a reflux condenser, then flushed with nitrogen. The reaction mixture was allowed to reflux for 23 
hours, at which point TLC had indicated the total consumption of the starting aldehyde and the 
reflux was stopped. The reaction mixture was allowed to cool to room temperature then chilled 
to precipitate the product. The precipitate was filtered and the filtrate acidified by bubbling CO2 
through until a pH of 8.0 was attained. The filtrate was concentrated via rotary evaporation, dried 
in a desiccator for multiple days and combined with the precipitate afforded 0.8824 g of a bright 
yellow solid (124%). 
 The product was placed into an Erlenmeyer flask where upon 20 mL of dichloromethane, 
4 mL of trimethylamine and 8 mL of distilled H2O was added. With stirring, CO2 was bubbled 
through the mixture until the trimethylamine and aqueous phases became homogenous. This 
was transferred to a separatory funnel and the product was further extracted by two more 20 
mL additions of dichloromethane. The organic phases were combined, dried over MgSO4 and 
concentrated by rotary evaporation to afford a dark amber oil. Once dried, the sodium salt was 
formed by suspending the oil in ethyl acetate and first washing with 1 M HCl until the organic 
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phase indicated a pH of 2.0. The organic layer was then separated and a 1 M methanolic solution 
of sodium hydroxide was added until a pH of 8.0 was attained. This was then concentrated by 
rotary evaporation and dried in a desiccator for two days to afford 0.5430 g (69% isolated) of the 
sodium salt verified by ESI-LCMS and 1H NMR. 
Preparation of cinnamylidenepyruvate (23). 
Potassium (3E,5E)-2-oxo-6-phenylhexa-3,5-dienoate (Scheme 4, 23) was preparped from 
3.292 g (24.91 mmol) cinnamaldehyde, 2.804 g (25.48 mmol) sodium pyruvate, and 0.1123 g 
(2.808 mmol) NaOH were combined with 25 mL CH3OH before being placed under an atmosphere 
of N2 and heated to reflux for 17 h. The volume was observed to be heterogeneous with yellow 
solid, but TLC showed that the starting aldehyde was still present (25% CH3CN/CH2Cl2 Rf: 0.85) 
and concentrated to dryness with rotary evaporation. 0.4030 g (10.08 mmol) NaOH and 46 mL 
CH3OH were placed into the reaction vessel and heated at reflux for 3 h before the starting 
aldehyde was no longer visible by TLC. The yellow solid was collected by vacuum filtration, rinsed 
with two 100 mL portions CH3OH, and placed under vacuum overnight to afford 2.083 g (37% 
crude yield). CO2 was bubbled into the filtrate until it reached pH 8.0 before being concentrated 
to dryness with rotary evaporation before being combined with 150 mL 18Ω H2O and 75mL 
triethylamine (TEA). CO2 was bubbled into the mixture while on ice until it became homogeneous 
before being extracted with five 50 mL CH2Cl2. The organic portions were combined, dried over 
MgSO4, filtered, concentrated with rotary evaporation, and placed under vacuum overnight to 
yield 2.050 g of an auburn oil. The oil was combined with 100 mL EtOAc, heated to boiling, 
decanted from the remaining undissolved semisolid, and cooled to room temperature. The 
supernatant was combined with 1.643 g (9.013 mmol) potassium 2-ethylhexanoate (K-2EHA) 
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dissolved in 30 mL EtOAc which produced a precipitate. The solid was collected by centrifugation, 
washed with two 30 mL portions EtOAc, and placed under vacuum overnight to remove residual 
solvent to afford 0.433 g of crude cinnamylidenepyruvate as a yellow solid. Initially, 2.045 g of 
the isolated yellow solid was dissolved in 185 mL 2.4 M triethylammonium bicarbonate (TEABC) 
and extracted with four 50 mL portions CH2Cl2. The organic extracts were combined, dried over 
MgSO4, filtered, concentrated with rotary evaporation, and placed under vacuum overnight to 
yield 1.0963 g of an auburn oil. The oil was combined with 50 mL EtOAc and stirred at room 
temperature before the supernatant was decanted and mixed with 0.8073 g (4.429 mmol) K-
2EHA producing a solid upon mixing. The solid was collected by centrifugation, washed with three 
30 mL portions EtOAc, and dried under vacuum to afford 0.7836 g of crude 
cinnamylidenepyruvate as a yellow solid. Cinnamylidenepyruvate was crude at 1.118 g, was 
recrystallized from 55 mL CH3OH and 100 mL EtOAc, boiled down to 1/3 of the total volume, and 
stored in a -10 ˚C freezer overnight. The resulting solid was collected by centrifugation and dried 
under vacuum to yield 0.914 g cinnamylidenepyruvate, as a yellow solid (15% yield, 99.4% 
cinnamylidenepyruvate, 0.6% by mass pyruvate, mp = 204 ˚C (darkens to tan), 228 ˚C (shrinks, 
darkens to brown). 
1H NMR (300MHz, D2O): δ7.63 (d, J=8.1Hz, 2H); 7.51 (qAB, J=15.6Hz, 9.6Hz, 1H); 7.48-7.41(m, 3H); 
7.20-7.07 (m, J=15.6Hz; 8.7Hz, 2H); 6.40 (d, J=15.6Hz, 1H) 
13C NMR (300MHz, D2O): δ198.3; 173.0; 151.7; 144.7; 136.4; 130.6; 129.7; 128.4; 127.4; 126.0 
ESI-MS (DUIS, + ion):  519 (2M + K+, 100%); 279 (M + K+, 96%)  
ESI-MS (DUIS, - ion): 441 (2M- + K+, 89%); 201 (M-, 100%) 
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Preparation of 4-nitrocinnamylidenepyruvate (24). 
Potassium (3E,5E)-6-(4-nitrophenyl)-2-oxohexa-3,5-dienoate (Scheme 4, 24) synthesis 
began with 1.456 g (8.222 mmol) trans-4-nitrocinnamaldehyde and 1.351 g (12.28 mmol) sodium 
pyruvate, suspended in 25 mL. NaOH, 0.1133 g (2.832 mmol), was dissolved in 25 mL CH3OH, 
added to the reaction mixture, and quantitatively transferred with 10 mL CH3OH. The mixture 
was placed under an atmosphere of N2 and heated at reflux for 3.5 h before the starting aldehyde 
was no longer visible by TLC (25% CH3CN/CH2Cl2 Rf: 0.87). The mixture was allowed to cool to 
room temperature, concentrated with rotary evaporation, and placed under vacuum overnight 
to afford 2.133 g of a brown solid. The crude product, 2.132 g, was added to 120mL 18Ω H2O and 
100mL TEA. CO2 was bubbled into the mixture until it became homogeneous, extracted with six 
100 mL portions CH2Cl2. The organic extracts were combined, dried over MgSO4, filtered, 
concentrated with rotary evaporation, and placed under vacuum to yield 2.372 g of a dark brown 
solid. The dark brown solid was 1.539 g and was mixed with 140 mL EtOAc. That was heated to 
boiling before the supernatant was decanted, cooled to room temperature. Potassium 2-
ethylhexanoate, 1.357 g, was dissolved in 50mL EtOAc was added to the supernatant, producing 
a precipitate. The solid was collected by centrifugation, washed with two 40 mL portions EtOAc, 
and dried under vacuum to produce 0.2123 g of the crude product which was recrystallized from 
12 mL CH3OH and 15 mL EtOAc. After concentrating to 10 mL total volume the mixture brought 
to room temperature and placed on ice for several minutes before collecting the solid by 
centrifugation and drying under vacuum to yield 0.1257 g (5% yield) trans-4-
nitrocinnamaldehyde (98% pure, 2% pyruvate mp = 198˚C (darkens from brown to dark brown). 
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1H NMR (300MHz, D2O): δ8.21 (d, J=8.4Hz, 2H); 7.72 (d, J=8.7Hz, 2H); 7.46 (qAB, J=15.3Hz, 8.4Hz, 
1H); 7.20 (m, 2H); 6.46 (d, J=15.6Hz, 2H) 
13C NMR (300MHz, D2O): δ198.9; 173.6; 150.9; 149.0; 144.1; 142.4; 132.3; 129.9; 129.0; 125.8 
MS (DUIS, + ion): 324 (M + K+, 89%), 150 (C8H7NO2 + H+, 100%) 
MS (DUIS, - ion): 531 (2M-+K+, 65%); 493 (2M-+H+, 69%); 246 (M-, 38%); 202 (M- - CO2, 100%);  
Steady State Enzyme Kinetics.  
All 0.5 mL kinetic assays were conducted in triplicate at 25 °C in 50 mM Bis-Tris (pH 7.0) 
for Table 2. The kinetic assays observed in Table 3 and 4 were also at 25 °C, but in 100 mM Bis-
Tris pH 6.5 on a TgK DX2 stopped-ﬂow instrument. The initial velocity of Sbi_00515-catalyzed 
hydrolysis of 1 was measured directly by monitoring the decrease in absorbance at 330 nm. 
Likewise, initial velocities of Sbi_00515-catalyzed condensation of pyruvate with various 
aldehyde substrates was also monitored directly. Extinction coeﬃcients and optimal wavelengths 
for monitoring the reactions are listed in Table 2. The extinction coeﬃcients were determined 
empirically by comparing appropriate peaks in the proton NMR spectra of the various enone 
products produced in the condensation reactions with the peak for the α-proton of tryptophan 
(added to the NMR samples as a standard) to estimate the concentration of the product. The 
tryptophan stock concentration was calculated from the absorbance at 280 nm and the known 
extinction coeﬃcient (5540 M−1 cm−1) 7. The kcat and KM values were determined from the initial 
velocity data using the equation v0 = Vm[A]/(KM + [A]), where [A] is the concentration of the 
aldehyde or benzylidenepyruvate substrate, v0 is the initial velocity, Vm is the maximal velocity, 
and KM is the Michaelis constant. 
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High-Performance Liquid Chromatography (HPLC) Analysis of Sbi00_515 Reaction Mixtures. 
Reaction mixtures (500 μL) containing 12.3 mM 1 in 50 mM sodium phosphate (pH 7.4) 
and 5.7 μM enzyme, as well as authentic standards of 1 and 2, were separated using a 50 mm × 
2.0 mm, 2.5 μm Synergy Polar RP column (Phenomenex) on an Agilent 1220 HPLC system. The 
gradient ran from 5 to 50% acetonitrile in a 0.1% TFA/water mixture over 8 min at a ﬂow rate of 
0.5 mL/min. Analytes were detected by absorbance at 260 nm. All samples were incubated for 
50 min at RT before being passed through 10k molecular weight cutoﬀ centrifugal ﬁlter devices 
to remove the enzyme. 
1H NMR Analysis of Sbi_00515 Reaction Mixtures.  
Reaction mixtures (500 μL) contained 2.8 μM Sbi_00515 and 12.5mM 1 or 50mM 2 with 
50 mM pyruvate in 50 mM sodium phosphate buﬀer (pH 7.4). The reaction mixtures were 
incubated at RT for 80 min (1) or 35 min (2 with pyruvate), after which the samples were 
evaporated to dryness in a CentriFan centrifugal evaporator. The residues were resuspended in 
500 μL of D2O. NMR spectra were recorded at RT on a Bruker DRX500 500 MHz spectrometer 
equipped with a BBI probe. All data sets consisted of 128 scans. Standard samples of 1 (12.5 mM) 
and the mixture of 2 with pyruvate (50 mM each) were treated in the same way as the enzymatic 
reaction mixtures. 
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3.3 Results and Discussion 
Sbi_00515 was ﬁrst assayed for acetoacetate decarboxylase activity as described by 
Highbarger et al 8. Because Sbi_00515 shares the same active site residue changes relative to 
CaADC that were observed in ShMppR, it was not surprising that it did not react with 
acetoacetate. As ShMppR was shown to react with pyruvate, a number of α-keto acids, including 
glyoxylate, pyruvate, oxaloacetate, and α-ketoglutarate, were tested as substrates for Sbi_00515. 
While glyoxylate, 
pyruvate, and α-
ketoglutarate were 
observed to form 
Schiﬀ base 
complexes in X-ray diﬀraction experiments, and the enzyme binds pyruvate with a KD of 5.7 ± 0.6 
mM as measured by ﬂuorescence titration, none of these were decarboxylated by the enzyme as 
judged from HPLC analysis of reaction mixtures. 
 
 
 
Scheme 1. Sbi_00515 catalyzed reaction of benzylidenepyruvate (1). 
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Figure 16. (A) Sbi00515-catalyzed cleavage of 1 observed by UV−vis spectroscopy. The spectra are separated by 4.5 min and 
thus cover a 90 min period. The 500 μL reaction mixture contained 100 mM 1 and 12.8 μM Sbi_00515 in 10 mM MES (pH 
6.0). The reaction was initiated by the addition of enzyme. (B) HPLC analysis of reaction mixtures and authentic benzaldehyde 
(2) suggests that Sbi_00515 catalyzes the hydrolysis of 1 to give 2 and pyruvate (3). Starting material (1, blue trace) and 
benzaldehyde, the putative product (2, red trace), are very well resolved, eluting at 6.3 and 3.9 min, respectively. A sample 
containing 12.3 mM 1 and 5.7 μM Sbi_00515 (green trace) clearly shows a loss of starting material with corresponding 
accumulation of a product that also elutes at 3.9 min under these conditions. (C) Proton NMR spectra of reaction mixtures 
and standards confirm that the products of the reaction between Sbi00515 and 1 are 2 and pyruvate. The authentic starting 
material (1, red trace) gives a spectrum that is distinct from that of benzaldehyde (cyan trace). The doublet at 6.8 ppm is 
characteristic of the unsaturated bond. The methyl protons of pyruvate give a singlet at 2.25 ppm (cyan trace). After 
incubation with the enzyme, pyruvate is clearly present (green trace). Given 50 mM pyruvate, the reaction can be run in 
reverse (purple trace), where the doublet at 6.8 ppm confirms the production of 1. Together, these data confirm that 
Sbi_00515 has in vitro aldolase-dehydratase activity.  
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 The similarity of the Sbi_00515 structure to that of ShMppR suggested that it should be 
able to react with α-keto acids. Sbi_00515 was tested for activity with benzylidenepyruvate [1 
(Scheme 1)], as any reaction resulting in modiﬁcation of the double bond (e.g., hydration) would 
disrupt the chromophore and be accompanied by a change in the UV−vis absorbance spectrum. 
UV−vis spectroscopy (Figure 16 A) 
showed that incubation of 1 with 
Sbi_00515 resulted in the time 
dependent loss of absorbance at 300 
nm and a concomitant increase in 
absorbance at 254nm. The structure 
of 1 and the rise of a species 
absorbing at 254 nm suggested that 
1 was being hydrolyzed to give 
benzaldehyde (2) and pyruvate [3 
(Scheme 1)]. Comparison of the 
reaction mixtures with pure 
pyruvate and benzaldehyde by reverse phase HPLC analysis confirmed that these were the 
products of the reaction (Figure 16 B). This was confirmed further by 1H NMR spectroscopy 
(Figure 16 C). These data clearly indicate that Sbi_00515 was able to hydrate the double bond of 
1 and catalyze the retro-aldol cleavage to give benzaldehyde and pyruvate. This same reaction 
has been observed in the trans-o-hydroxybenzylidenepyruvate hydratase-aldolase from 
 
Scheme 2. Aldehydes used in substrate screen I (Table 2). 
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Pseudomonas fluorescens, though this enzyme appears, from secondary structure prediction, to 
have the TIM barrel fold typical of Schiﬀ base-forming aldolases 9, 10.  
Since these end-point assays were conducted over relatively long time periods (30−120 
min), it was possible that the reaction observed was cryptic and did not represent the 
physiological activity of the enzyme. To address this question, both the hydrolysis and 
condensation reactions were characterized by steady state enzyme kinetics. Though the 
reactions are clearly catalytic, the modest values of the pseudo-second-order rate constants of 
54, 62, and 100 M−1 s−1 when 1, 2, and 3 are varied, respectively (Table 2), suggested either that 
these compounds are nonideal substrates that participate in a facsimile of the native reaction for 
this enzyme or that they induce nonphysiological chemistry that is only evidence of reaction 
promiscuity. To clarify this point, a number of additional aldehyde substrates (Scheme 2) were 
screened for activity with saturating pyruvate (Table 2). Interestingly, 4-hydroxybenzaldehyde (4) 
has a pseudo-second-order rate constant comparable to that of 2; however, the KM value is 
approximately 200-fold less than that of 2, and kcat is more than 300-fold slower. This may 
indicate that Sbi_00515 binds 4 more tightly, but in an orientation that is less favorable for 
catalysis. Moving from the aryl aldehyde 2 to aliphatic aldehydes 5−11 results in a marked 
improvement in KM with small decreases in kcat, such that the catalytic efficiency improves by as 
much as 2 orders of magnitude. There is a clear trend of decreasing KM with increasing chain 
length going from 6.6 ± 0.4 mM for 5 to 35.0 ± 2.0 μM for 11. There is no clear relationship 
between substrate size and the kcat values.  
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Table 2. Steady State Kinetic Parameters Measured for the Reaction of 2.0 μM Sbi_00515 with the Enone Substrate 1 in the 
Absence of Pyruvate or in the Presence of Saturating Concentrations of Pyruvate (50mM) and Various Aldehyde Substrates 
(see Schemes 1 and 2), Subsaturating Concentrations of 2 (50mM) and Pyruvate (3), or Saturating Concentrations of 12 
(10mM) and Pyruvatea 
 product 
substrate kcat (sec-1) KM (mM) kcat/KM (M-1 sec-1) λmon (nm) ε (M-1 cm-1) 
benzylidenepyruvate (1) 1.2 ± 0.2 22.3 ± 7.0 5.4 ± 1.9 x 101 300 24159 
benzaldehyde (2) 3.2 ± 0.2 51.5 ± 6.1 6.2 ± 0.8 x 101 300 11426 
4-hydroxybenzaldehyde (4) 0.01 ± 0.001 0.4 ± 0.1 2.5 ± 4.0 x101 360 1217 
trans-2-pentenal (5) 1.2 ± 0.1 6.6 ± 0.4 1.8 ± 0.1 x 102 290 26021 
trans-2-hexenal (6) 12.9 ± 0.6 1.8 ± 0.1 7.2 ± 0.5 x 103 290 8576 
hexanal (7) no reaction ‒ ‒ ‒ ‒ 
2,4-heptadienal (8) 0.90 ± 0.04 0.3 ± 0.02 3.0 ± 0.2 x 103 360 2432 
trans-2-octenal (9) 7.8 ± 0.3 0.4 ± 0.04 2.0 ± 0.2 x 104 330 447 
2,4-octadienal (10) 7.2 ± 0.2 0.7 ± 0.1 1.0 ± 0.1 x 104 380 1613 
3,7-dimethyl-2,6-octadienal 
(citral, 11) 
0.28 ± 0.01 0.04 ± 0.002 7.0 ± 0.4 x 103 330 3393 
trans-3-(2-furyl)acrolein (12) 22.9 ± 0.8 1.2 ± 0.08 1.9 ± 0.1 x 104 390 10062 
pyruvate (3)b 1.8 ± 0.1 17.2 ± 2.8 1.0 ± 0.2 x102 300 ‒ 
pyruvate (3)c 22.5 ± 1.2 11.8 ± 1.6 1.9 ± 0.3 x 103 390 ‒ 
aAs described in the text, the poor binding and limited solubility of 2 made it impossible to fully saturate the enzyme. The 
kinetic parameters apply to the substrate in column 1. The extinction coefficients given are for benzylidenepyruvate itself (row 
1) and the condensation products of pyruvate with the aldehyde substrates tested (remaining rows). bBecause of the high KM 
value for 2, reaction mixtures were not saturated with respect to this substrate. cReaction kinetics of pyruvate with 12 were 
nearly saturated (the concentration of 12 was about 10-fold greater than the measured KM value). 
 
The complete lack of activity with 7, as judged by HPLC analysis shows that the unsaturated bond 
adjacent to the aldehyde group is required for the observed catalysis. There also does not appear 
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to be a relationship between the kinetic values for 9 and 10, suggesting that the chemistry is 
taking place between the aldehyde 
and pyruvate. The greater the 
degrees of freedom of 9 due to its 
lack of a second double bond is 
negligible. The tunnel from the 
surface to the active site may force 
9 to adopt a conformation that 
mimics the shape of 10. The β-
methyl of 11 is likely responsible 
for the slower kcat compared to 10 
and 12, as the protruding 
functional group sticks out into the 
tunnel of the active site. 
The aromatic aldehyde 3-
(2-furyl)acrolein (12) was chosen because it combines a short, unsaturated alkyl chain with an 
aromatic group. This substrate was significantly more efficient than any of the other substrates 
tested with a kcat value of 22.9 ± 0.8 s−1 and a KM value of 1.2 ± 0.1 mM, for a pseudo-second-
order rate constant of 1.9 × 104 M−1 s−1. It is interesting to note that the diene substrate 8 reacts 
20-fold more slowly than 12 despite the high degree of similarity of their structures. The ability 
of the furan ring to accept a hydrogen bond and/or stack with an aromatic side chain in the active 
site may result in 12 binding in a more favorable orientation for catalysis. 
 
Scheme 3. Aldehydes used in substrate screen II (Table 3). 
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Table 3. Steady State Kinetic Parameters Measured for the Reaction of 0.1 μM Sbi_00515 in the Presence of Saturating 
Concentrations of Pyruvate (50mM) and Various Aldehyde Substrates (see Scheme 3), or Saturating Concentrations of 14 
(1mM) and Pyruvate. 
 product 
substrate kcat (sec-1) KM (µM) kcat/KM (M-1 sec-1) ε (M-1 cm-1) 
2-benzofurancarboxaldehyde (13)a 7.3 ± 0.2 699.4 ± 45.7 1.0 ± 0.1 x 104 10749 
trans-cinnamaldehyde (14) 28.3 ± 0.4 52.9 ± 1.6 5.4 ± 0.2 x 105 17050 
2-methoxycinnamaldehyde (15) 15.7 ± 0.4 100.2 ± 4.0 1.6 ± 0.1 x 105 11908 
4-methoxycinnamaldehyde (16) 3.3 ± 0.1 13.1 ± 0.9 2.5 ± 0.2 x 105 46035 
3-methoxy-4-hydroxycinnamaldehyde (17) 1.7 ± 0.1 117.2 ± 19.6 1.5 ± 0.3 x 104 34851 
3-(3-pyridyl)acrolein (18) 398.2 ± 2.3 191.6 ± 2.1 2.08 ± 0.03 x 106 5117 
α-methyl-trans-cinnamaldehyde (19) 2.0 ± 0.1 426.9 ± 58.8 4.7 ± 0.7 x 103 12624 
trans-2-nitrocinnamaldehyde (20) 24.7 ± 0.6 30.6 ± 3.0 8.1 ± 0.8 x 105 11963 
trans-4-nitrocinnamaldehyde (21) 10.2 ± 0.1 3.1 ± 0.1 3.3 ± 0.2 x 106 49616 
pyruvate (3)b 22.3 ± 0.4 2914 ± 181  7.7 ± 0.5 x 103 ‒ 
The λmon (nm) for each substrate was 360, except for a, which was 380 nm. bReaction kinetics of pyruvate with 14 were nearly 
saturated (the concentration of 14 was about 20-fold greater than the measured KM value). 
 
Finally, the relatively robust activity with 12 does suggest that the aldol condensation and 
dehydration activity of Sbi_00515 is real, and not a spurious reaction resulting from the presence 
of a reactive enamine in the active site. It should also be noted that the aldol condensation 
activity was observed only with pyruvate. Other α-keto acids that were tested, such as glyoxylate, 
2-oxobutyrate, oxaloacetate, and α-ketoglutarate, did not react with any of the aldehyde 
substrates used in this study. Like the Type I lysine-dependent aldolases, Sbi_00515 is specific for 
its donor substrate, pyruvate, and promiscuous with respect to the acceptor, aldehyde substrate. 
 An estimated 1 in 10 enzymes adopt the TIM barrel fold 11, or (β/α)8, fold including Type 
I and II aldolases. Type I aldolases have an essential active site lysine residue that is involved in 
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Schiff base formation 
with a donor substrate, 
pyruvate 12. Type II 
aldolases function with a 
metal ion, typically Zn+, as 
a cofactor 13. The general 
mechanisms for Type I 
and II aldolases are shown 
in Scheme 4. The Type I 
sialic acid aldolase, N-
acetylneuraminate lyase 
(NAL), catalyzes the reversible aldol cleavage of N-acetylneuraminic acid (Neu5Ac), the most 
abundant of sialic acids, to form pyruvate and N-acetyl-D-mannosamine (ManNAc) 12. Sialic acid 
aldolase, as mentioned in chapter 2, Figure 13, uses an active site lysine to form a Schiff base to 
C2 of an α-keto acid moiety of the substrate 12. The WT structure of Pasteurella multocida NAL 
shows the that the active site tyrosine (Tyr136) lies almost parallel to the Schiff base 
intermediate, and is involved in the hydrogen bonding network with the substrate 12. Tyr136 is 
proposed to take a hydrogen from the active site lysine, and transfer it to the carbonyl (C2) of 
pyruvate with the release of a water molecule. The structure, PDB ID 4IMD, shows a conserved 
water molecule 2.7 angstroms from Tyr 136 and 2.8 Å from the Schiff base intermediate. 
Although the study by Huynh et al. calls the pyruvate-bound structure the Schiff base 
intermediate, there is no way to tell at 2.10 angstrom resolution whether pyruvate is bound as 
 
Scheme 4. The general mechanisms for Type I and II aldolases. 
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the imine or enamine 12. Another study uses crystal structures, as well as quantum 
mechanics/molecular mechanics (QM/MM) and site-directed mutagenesis to test the catalytic 
importance of the active site tyrosine 14. This time, an E. coli NAL was used, and demonstrated 
Y137F had about 570-fold lower kcat/KM, with approximately the same KM values, and no activity 
with Y137A. QM/MM sampled molecular dynamics, and in all cases observed a spontaneous 
proton transfer from the active site Tyr137 to the ManNAc aldehyde oxygen 14. QM/MM also 
proposed the use of water in the breakdown of the Schiff base and the substrate/product, and 
reprotonate the Tyr137 phenolate 14. 
Adding a bulkier aromatic group than the furan ring of 12 continued to decrease KM values 
by an order of magnitude (compare values in Table 2 to 3). Comparing 12 and 13, the kcat values 
are approximately equal, while the KM values differ significantly. The combination of an 
unsaturated aliphatic aldehyde with a phenyl group is a better match to the shape of the funnel-
like active site. In contrast, active sites of the true ADCs are long, narrow tunnels, reflecting their 
smaller substrate 2. The lower KM values in Table 3 suggest that the increased bulk allows for 
more extensive van der Waals contacts between the aldehyde and the active site funnel. In 
addition, the aromatic group and trans double bond of the aliphatic portion of these aldehydes 
matches the shape of the active site and creates the potential for π-π interactions with aromatic 
side chains lining the funnel. While none of the cis counterparts of this series of aldehydes were 
tested for activity, one might speculate that they may not bind as well, since a cis compound 
would require a spontaneous cis-trans isomerization before it could be accommodated in the 
active site. 
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Trans-cinnamaldehyde (14) was a favorable scaffold for investigating the effects of 
substituents on the phenyl ring, as cinnamaldehyde analogs are commercially available. The KD 
for trans-cinnamaldehyde was 45.8 ± 4.1 µM. It would have been more advantageous to vary the 
same substituent around the phenyl ring to control for effects due to the identity of the 
functional group, however the compounds in Scheme 3 were those available for purchase. The 
ortho or para positions were more efficient substrates than those in the meta position. The para 
position for 16 and 21 had a smaller kcat, but a tighter KM than 15 and 20, leading to a higher 
pseudo-second-order rate constant. When 16 and 21 are modeled into the active site using the 
pyruvate-bound structure as an anchor for the pyruvate moiety, both of these compounds more 
completely filled the active site than 14, and 21 had a tighter KD at 14.36 ± 1.32 µM. The more 
extensive van der Waals contacts with these para-substituted cinnamaldehydes likely accounts 
for the lower KM values. The kcat values for 16 and 21 may be smaller than 15 and 20, which 
contain a methoxy and nitro group, respectively, in the ortho position, due to their positions 
further into the active site than the para positions. Therefore, the contacts are in the tunnel lining 
the active site, not with bulk solvent like the para versions, which could effectively shield them 
from any additional van der Waals interactions (15) or hydrogen bonding (20). Substituents in 
the meta position appear to interfere with binding, as evidenced by the the 16-fold slower kcat of 
17. The para substituent of 16 fully fills the active site in modeling, the meta position of 17 juts 
out into the hydrophobic residues lining the active site. Surprisingly, 3-(3-pyridyl)acrolein (18) has 
a much faster turnover number than the rest of the substrates in Table 3, however the KM is 
almost 200 µM. This could be due to 18 having a lone pair of electrons on the aromatic ring, 
which could influence how it binds in the active site. The α-methyl group of 19 clashes with the 
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active site, resulting in lower kcat and specificity 
constant. Based on the values from Table 3.2 for 
trans-4-nitrocinnamaldehyde, 21 is a highly efficient 
substrate, though not necessarily the physiological 
one. 14 was used with pyruvate for steady state 
kinetics in Table 3.2 due to better solubility. The 
steady state values for pyruvate from Table 3 
increased slightly for the pseudo-second-order rate 
constant, decreased for KM, yet maintained the same 
kcat compared to the values in Table 2. Perhaps there 
is a limit to the turnover number, and the subtle changes in apparent binding affinity and 
specificity constant reflect the preference for aromatic, unsaturated aliphatic groups for 
aldehyde acceptors. 
After substrates 2-21 were tested for the synthetic direction, specific substrates (12, 14, 
21) were chosen to combine with pyruvate to observe the reversibility of Sbi_00515 (22, 23, 24), 
as seen in Scheme 5. The compounds for catabolic catalysis are in Scheme 5, and steady state 
kinetics observed in Table 4. 
Table 4. Steady State Kinetic Parameters Measured for the Reaction of 0.1 μM Sbi_00515 in the Presence of 22, 23, or 24. 
 product 
substrate kcat (sec-1) KM (µM) kcat/KM (M-1 sec-1) ε (M-1 cm-1) 
3-(2-furyl)acrolenepyruvate (22)a 0.21 ± 0.02 52.9 ± 8.3 4.0 ± 0.7 x 103 10,062 
cinnamylidenepyruvate (23) 1.57 ± 0.04 24.9 ± 1.7 6.3 ± 0.5 x 104 17,050 
4-nitrocinnamylidenepyruvate (24) 0.68 ± 0.04 8.5 ± 0.9 8.0 ± 1.0 x 104 49,616 
The λmon (nm) for each substrate was 360, except for a, which was 390 nm. 
 
Scheme 5. Compounds used for retro-aldol 
cleavage (Table 4). 
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The benzyl groups of 23 and 24 are an order of magnitude greater in their specificity constants 
than that of the furyl ring of 22. The better KM values of 23 and 24 compared to 22 suggest the 
former fills out the active site more fully, by forming more π-π stacking and van der Waal 
interactions. 24 has a slower turnover rate than 23, which may be due to better KM values. 
Nevertheless, 22-24 are all 1-2 orders of magnitude lower in pseudo-second-order rate constants 
when contrasted against their synthetic, anabolic counterpart reaction. If there is excess 
pyruvate in the bacterium 15, that would drive catalysis in the synthetic direction.  
 
Scheme 6. Non-reactive compounds for Sbi_00515 with saturating pyruvate (3). 
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Numerous other small compounds were tested in saturating, 50mM pyruvate that 
demonstrated no activity with Sbi_00515 (Scheme 6). First, other benzaldehyde-like compounds 
were tried. 25-27 may have been influenced by the electronegative atoms within the ring to 
explain why no reaction with pyruvate and Sbi_00515 occurred. There also could have been 
unfavorable or unreactive binding in the active site. Benzaldehyde derivatives 28 and 29 did not 
react. This is likely due to benzaldehyde being a modest substrate to begin with, and the 
additional electronegative nitrogens could have had an inductive effect, bound to a functional 
group in the active site to prevent catalysis, or not being able to bind Sbi_00515 without greater 
than mM quantities. Compound 30 was tested to compare to the 2-benzofurancarboxaldehyde 
compound (13), and the fact that a nitrogen in the ring system could behave, as 3-(3-
pyridyl)acrolein does. 30-34 were tested as a confirmation that only an unsaturated aliphatic 
aldehyde would reaction. Hydrocinnamaldehyde, 30, has too many degrees of freedom to 
undergo catalysis. There is no unsaturation in the aliphatic portion to keep 30 in a conformation 
near the aldehyde to direct it towards the pyruvate in the active site for catalysis. 32 ‒ 34 
confirmed that an aldehyde was the only functional group able to react with pyruvate in 
Sbi_00515.  
 
3.4 Conclusions 
 The steady state kinetic data presented here show that Sbi_00515, a protein of unknown 
function from S. bingchenggensis, has in vitro pyruvate aldolase-dehydratase activity and is not 
an acetoacetate decarboxylase as it is currently annotated. Based on this activity, it is proposed 
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that Sbi_00515 be renamed to Streptomyces bingchenggensis Aldolase-Dehydratase, SbAD. This 
is the first Schiff base-forming aldolase known to use a fold other than the TIM barrel. Given the 
proximity of the gene encoding SbAD to an uncharacterized polyketide biosynthetic cluster and 
the strong preference for an unsaturated aldehyde substrate, it is tempting to speculate that 
SbAD might synthesize an unusual starter or extender unit for the polyketide. However, more 
detailed genetic and biological studies must be conducted before anything substantive can be 
concluded in this regard. Other lysine dependent (TIM barrel) aldolases have been used in protein 
engineering and as templates to generate enzymes that catalyze reactions not found in nature, 
as mentioned in the introduction of chapter II 16, 17. The discovery of SbAD and the versatility of 
the ADC fold may influence how proteins are engineered, but more mechanistic studies need to 
be done. Numerous work has been done on TIM barrels, as mentioned previously, for 
engineering, however the ADC fold has not been considered in these endeavors. The funnel of 
the active site, lined with hydrophobic residues, could be engineered with bulkier groups to 
narrow the site, or changed to polar groups and accept for hydrogen bonding substrates. ADC 
could function as a group to hold potential active sites of designed transition states as de novo 
work, however it remains to be tested. 
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CHAPTER IV: ELUCIDATING THE MECHANISM OF SbAD  
4.1 Introduction 
 Steady state kinetics can indirectly probe the order of addition of substrates and release 
of reactants and products however transitory intermediate information after the substrate(s) 
bind is not observable by this technique 2. The pre-steady state, with half-times of less than one 
second, is the initial period during which intermediates form, and lasts until the steady state is 
reached 3-5. The most widely used method of studying fast reactions is stopped flow 3. Figure 17 
illustrates the basic set-up of the instrument. Rapid spectral acquisition via stopped flow can be 
done by diode-array or a photomultiplier tube (PMT) 2. Diode-array mode can detect and 
integrate all of the light for the exposure time to record a snapshot of the spectrum of the 
reaction solution by 
using a high-intensity 
xenon lamp, whereas 
PMT mode observes a 
reaction at a specific 
wavelength 2. The 
diode-array mode has 
a loss in time 
resolution, but covers 
a range of 
wavelengths, whereas 
 
Figure 17. Simplified schematic of a stopped flow apparatus, adapted from TGK Scientific 1. 
The drive syringes are labeled A and B. 
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a specified wavelength in PMT mode has excellent time resolution. Arrays may not always be 
able to show parts of the spectrum of interest, but may show intermediates one might not see 
at a single wavelength (e.g. if the reaction were being monitored at an isosbestic point). The 
reaction is started by pushing the plungers of the two drive syringes simultaneously to cause the 
reactants to mix. The mixture is then forced through the observation cell, and into the stopping 
syringe 3. The mechanical stop activates the detecting and recording system, as well as prevents 
further mixing. The time between the start of mixing and the start of recording, for instance, 
absorbance, is known as the dead time, during which the reaction cannot be observed. For most 
instruments it is usually on the order of a 1‒2 milliseconds 3, 7. Steady state kinetics forms the 
basis of transient state kinetics 8. 
 Most experiments are done under pseudo-first order conditions in order to simplify a 
reaction. The benefit of this in transient kinetics is the direct measurement of reactions at the 
enzyme active site in order to determine the thermodynamic (equilibrium) and kinetic 
foundations for enzymatic specificity and efficiency 9, 10.  Even under pseudo-first-order 
conditions, the data can deviate from a simple, single exponential. One such deviation is a burst 
phase at the earliest time points, which is indicative of a build-up of intermediate on the way to 
the establishment of the steady state 2. Burst kinetics may indicate a covalent intermediate in 
the reaction, or that product release is the rate-limiting step in the mechanism. The magnitude 
of the intercept of the burst is typically proportional to the enzyme concentration 3. There may 
also be deviations from simple, monophasic data that can arise due to contributions from more 
than one intermediate during a time course 5. One method to resolve such ambiguities is single-
turnover kinetics. The enzyme in excess over substrate concentration allows for direct 
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observation of the conversion of substrates to intermediates and products in a single pass of the 
reactions through the enzymatic pathway 9. Reactant can be titrated, or chemical agent is added 
to stop the reaction after one turnover 11. Although this method can directly determine rate 
constants, an excess of enzyme is not a trivial matter, as depending on the binding constants of 
the substrates used, this might require a large or even unrealistic concentration of protein. 
 The goal of data fitting in transient kinetics is to establish the reaction pathway by 
investigating the concentration dependence on the rate of the reaction 9. Unlike steady state 
kinetics, which fit initial rate data via simple linear regression, pre-steady state kinetic data are 
fit to integrated equations from simple (pseudo-first order) rate equations. This involves fitting 
the data to an equation fitting the time dependence of the reaction. Solutions of differential 
equations describing the pseudo-first order reaction will be a sum of exponential terms, with a 
single exponential as an example: 
𝑌 = 𝐴𝑒−𝑘𝑡 + 𝐶 
where A is the amplitude, k is the rate of the reaction, t is the time, and C is the end point 9. 
Nonlinear regression methods are used in an iterative approach for best fit, including the 
minimization of the sum of square error between the fitted and raw data 9. Throughout the data 
fitting process, overfitting the data is a cause for concern. Programs that solely use singular value 
decomposition may rely too heavily on Chi2 values, instead of global fitting, as found by the work 
of K. Johnson 11-14.  Computer simulations of a proposed kinetic mechanism is another important 
method to determine the validity of the rate constants obtained experimentally from transient 
(as well as steady state) kinetics. A model of the proposed mechanism is fit to rate constants (and 
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other values in global fitting), and allowed to digitally proceed. The comparison of the modelled 
mechanism and experimental values indicate the accuracy of the predicted mechanism, whereby 
overfitting is again cause for misleading rate constants 11. 
Steady state and transient kinetics are complementary techniques. For instance, a 
transient single turnover kinetic experiment may give clues about the order of addition of a two 
substrate reaction, but not conclusive results. In that case, initial velocity studies with inhibitors 
is another approach to distinguish between possible mechanisms 2. Different approaches can be 
used, depending whether the enzyme exhibits substrate or product inhibition, allosteric 
regulation, tight-binding/slow-binding inhibition, or whether an inhibitor binds irreversibly or 
reversibly in the active site. In reversible inhibition, different types of inhibition are possible, 
based on the classic definitions: competitive, mixed, uncompetitive, or pure noncompetitive 
inhibition 2, 3, 15. Illustrations of the terminology are in Figure 18; this is necessary as even within 
the field there is not good agreement as to what these terms actually mean. Plots of the initial 
velocity experiments shed light on the type of inhibition used based on fitting the experimental 
data 16, 17.  
 
Figure 18. Simplified examples of inhibition, where A is substrate, E is enzyme, I is inhibitor, and P is product. (A) Competitive 
inhibition: Apparent increase in KM, no change in V. (B) Mixed inhibition: apparent V and V/KM are decreased. (C) 
Uncompetitive inhibition: Apparent V is decreased, V/KM unchanged. Not pictured is rare, pure non-competitive inhibition: 
apparent V decreased, KM unchanged 3. 
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 One of the most powerful physical organic chemistry tools in mechanistic enzymology is 
the kinetic isotope effect (KIE), as it can describe what bonds have been broken, formed, or 
rehybridized during a rate-limiting step 3, 18.  A KIE can be defined as “a change in the rate or 
equilibrium constant of a reaction upon substitution of a heavy atom for a light one at or adjacent 
to the position of bond cleavage in a molecule undergoing reaction.”2 Isotopes are isosteric and 
isoelectronic as they reflect changes in vibrational frequencies of reactants going to products, 
and therefore do not alter the mechanism of a reaction, just the observed rate constant of a 
sensitive step 2. A primary isotope effect occurs when a bond is made or broken to the isotopic 
(heavy) atom during a reaction, and a secondary isotope effect occurs when the bonding to the 
isotopic atom changes, but no bonds were broken or made 19, 20. A secondary KIE is largely due 
to hybridization changes, whereas a primary KIE mainly arises from the difference in mass on 
vibrational energy levels. If the heavy atom is attached to the bond undergoing cleavage, it is 
known as α, whereas if it is in a position attached to an atom adjacent to the one undergoing 
cleavage, it is known as β. When the bonds being made, broken, or rehybridized involve 
hydrogen/deuterium, the effect is relatively large and can be measured. KIEs with other atoms 
have been studied, but the effects are small and difficult to quantify 18. Isotope effects are given 
as the ratio of rate constants with light and heavy atom substitutions, for instance 
𝑘𝐻
𝑘𝐷
⁄ . The 
ratio is said to be “normal” if it is above unity, or one, and “inverse” if it is less than one. There 
are three ways to measure isotope effects: direct comparison of initial rates, equilibrium 
perturbation, and the most sensitive method, internal competition, as it follows the changes in 
the isotopic ratio as the reaction proceeds 2, 21. Like all kinetic measurements, careful attention 
needs to be paid to the proposed step at hand, as overfitting data can affect analysis, or intrinsic 
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isotope effects on Vmax values may be masked by slower chemical steps that are not isotope-
sensitive 20, 22-24. 
 The techniques explored above are done in a buffer of specific pH, since enzymes are 
profoundly affected both structurally and functionally. Most enzymes possess a number of 
ionizable groups distributed across their surface and in the active site 3. A pH-rate profile can 
illustrate the required state of protonation of groups required for binding and/or catalysis, but 
may also reflect the stability of the enzyme over the pH range 2. Thus, pH-rate data are 
notoriously difficult to interpret. The estimated pKa value from a plot of log (V) versus pH, for 
example can be tested by mutating the residue in question to an amino acid that cannot ionize, 
and repeat the pH-rate profile for verification. Even in this case, though, the mutation might alter 
the environment of the active site and thus shift the pKa of a different residue; the observed 
effect of the mutation may not be due to the pKa of the mutated residue. A single or double 
 
Figure 19. The image is from Gill et al.6 for a DSC experiment. ΔT is the amount of heat required to raise the temperature by 
the same amount. qs and qr are the heat flows for the sample and reference cell, where qs requires more heat than qr due to 
the contribution of protein in the cell, Δq. The scan for qr is subtracted from qs to the resultant Δq. ΔHd is the change in 
enthalpy, ΔCp,d is the change in heat capacity, Tm is the transition and melting point, and d is denatured. 
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mutant in the active site of an enzyme can hint towards its involvement in catalysis and/or 
binding in a reaction. Sometimes, a mutant can not only drastically change the activity of an 
enzyme, it may alter substrate specificity, improve trace activities, or lead to a new reaction 
mechanism 25. Steady state and transient kinetics with active site (or other important site) 
mutants can further illustrate key residues involved in the mechanism. X-ray crystallography is 
another important tool for the characterization of active site mutants. A crystal structure of a 
mutant form of the protein may show new binding contacts, or trap an intermediate by slowing 
down or inhibiting the mechanism.  
Mutant forms of a protein may not crystallize in the same conditions as WT, leading to 
complications in enzyme stability. One method to quickly assess buffers, additives, and/or ligands 
for stabilization is by a thermal shift assay, also known as a differential scanning fluorimetry or a 
ThermoFluor™ assay 26. The goal of this technique is to establish a connection between 
temperature, and a specific physical property; in this case, the denaturation and aggregation of 
protein with increasing temperature to find conditions that stabilize the protein. This rapid and 
inexpensive technique uses a real-time PCR instrument with the fluorescent SYPRO orange dye 
(λex 470 nm/λem 570 nm). SYPRO orange fluoresces upon binding to hydrophobic portions of the 
protein, which become more available as the temperature increases and the protein begins to 
denature. Monitoring the fluorescence emission as a function of temperature gives a change in 
the emission of the dye that indicates the point where 50% of the protein molecules have 
denatured: the melting temperature (Tm).  
Once buffers, potentially small molecule additives, have been optimized, one can directly 
determine the thermodynamics of protein unfolding in more detail by using differential scanning 
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calorimetry (DSC). DSC has numerous applications from chemistry to pharmacology and 
nanoscience, however one of the focuses in biochemistry, is protein folding 6. When a 
macromolecule unfolds, a change in heat capacity is observed. The heat capacity of a folded 
protein is higher, because it takes energy to surpass the phase change of folded to unfolded 
protein 27. The increasing disorder of the protein as the temperature rises produces the heat 
capacity in the aqueous solution 6. The simplest DSC experiment consists of a reference cell, filled 
with only the buffer, and a sample cell, containing the macromolecule in the exact same buffer. 
The temperatures of both cells are simultaneously raised. The amount of excess heat absorbed 
or released by the molecule in the sample requires the input energy to match the temperature 
of the sample to that of the reference 6. Therefore, more energy is required to bring the sample 
cell, containing the protein in buffer, to the same temperature as the reference. The power 
compensation signal is recorded as the calorimetric output 28. Figure 19 shows a schematic of a 
DSC experiment and data analysis. The enthalpy can also be calculated in an indirect, non-
calorimetric manner by van’t Hoff analysis 27. This takes an equilibrium constant (K) so that the 
standard free energy change, ΔG°, is zero so that: 
𝛥𝐺°(𝑇) =  −𝑅𝑇 ln 𝐾(𝑇) 
where R is the universal gas constant and T is the temperature in Kelvin, and: 
𝛥𝐺°(𝑇) =  𝛥𝐻°(𝑇) − 𝑇𝛥𝑆°(𝑇) 
where ΔH° is the change in enthalpy and ΔS° is the change in entropy. Combining the equations 
produces 
ln 𝐾(𝑇) = (
−𝛥𝐻(𝑇)
𝑅
)(
1
𝑇
) + (
ΔS°(T)
𝑅
) 
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and rearrangement gives the van’t Hoff equation 
𝑑 ln 𝐾(𝑇)
𝑑 (1 𝑇⁄ )
=  
−𝛥𝐻°(𝑇)
𝑅
 
If the enthalpy change derived from the van’t Hoff analysis agrees with the value determined by 
DSC, then the denaturation process of the protein can be approximated by a two state model, 
which states the protein exists in two forms, folded and unfolded 28. If the van’t Hoff enthalpy 
value is less than the DSC value, an intermediate during unfolding is likely to have formed 29.  
 SbAD has undergone ThermoFluor™, DSC, and van’t Hoff analysis to more thoroughly 
understand its stability. Based on substrate specificity and functional analysis, cinnamaldehyde 
and 4-nitrocinnamaldehyde with saturating pyruvate have been used for study in the synthetic 
direction, and cinnamylidenepyruvate and 4-nitrocinnamylidenepyruvate for the catabolic 
direction. The proposed mechanism (Figure 20), is based on the observed aldolase-hydratase 
activity, and the conserved Schiff base-forming residues from the true ADCs. First, pyruvate binds 
in the active site. A carbinolamine is formed on the way to a Schiff base intermediate. The 
aldehyde is oriented by Tyr252 before nucleophilic attack to the carbonyl carbon of the aldehyde. 
An aldol intermediate is formed, as well as another Schiff base, and then hydrolysis from the 
enzyme occurs for product release. 
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4.2 Materials and Methods 
Materials 
 Cinnamaldehyde, 4-nitrocinnamaldehyde, 2,3-butanedione, 4-phenyl-3-buten-2-one and 
sodium pyruvate were sourced from Sigma-Aldrich. 
Cloning, Expression, and Purification of Sbi_00515.  
The protein was previously cloned and expressed as described in Chapter II 30. 
Preparation of cinnamylidenepyruvate. 
The compound was previously synthesized as described in Chapter III. 
Preparation of 4-nitrocinnamylidenepyruvate. 
The compound was previously synthesized as described in Chapter III. 
Transient Kinetics. 
Photodiode array data were collected on a TgK DX2 stopped flow instrument under single 
turnover conditions. A solution containing saturating, 500 µM, wild-type SbAD was mixed with 
an equal volume of 17 µM cinnamaldehyde and 50 mM sodium pyruvate (all concentrations 
represent concentrations in the optical cell after mixing). Reactions were monitored at 
wavelengths ranging from 317 ‒ 703 nm at 0.8 ‒ 0.9 nm intervals, at 5.0 °C for a total of 1.49 
seconds in 50 mM BIS-TRIS pH 7.0. The same conditions were used to study the reverse reaction, 
where 17 µM cinnamylidenepyruvate was mixed with 500 µM SbAD WT. 
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Transient state kinetics were also done under pseudo-first order conditions to probe the 
order of addition. SbAD WT was 491 µM, and saturating pyruvate was 60 mM. The 
cinnamaldehyde concentrations varied were 10, 15, 20, 25, 30, 35, and 40 µM final, and buffer 
used was 50 mM BIS-Tris pH 7.0. All reactions were at 5.0 °C. Wavelengths were monitored at 
360 nm and 430 nm; all reactions were done in triplicate on a 1.0 second time scale. All fitting 
was done in OriginPro 2016 Student Version 64Bit. 
Kinetic isotope effects with substrates 1H3 and 2H3 pyruvate were done at 5.0 °C in single 
turnover conditions. Pyruvate was saturating, 60 mM. Cinnamaldehyde concentrations were 20, 
25, 30, 35, and 40 µM final. Experiments were performed on a TgK DX2 stopped flow instrument 
with 491 µM SbAD WT in 50 mM BIS-Tris pH 7.0. Wavelengths were monitored at 360 nm and 
430 nm; all reactions were done in triplicate on a 1.0 second time scale. All fitting was done in 
OriginPro 2016 Student Version 64Bit. 
Steady State Burst Kinetics. 
Time courses for the reactions with varying concentrations of SbAD WT with saturating 
200 mM pyruvate and 500 µM 4-nitro-cinnamaldehyde were performed at 4.0 °C in 50 mM BIS-
Tris pH 6.5. 
Steady State Inhibition Kinetics.  
All assays are the average of triplicate runs. The kinetic assays were done at 25 °C in 
triplicate in 100 mM Bis-Tris pH 6.5 on a TgK DX2 stopped-ﬂow instrument. The initial velocity of 
Sbi_00515-catalyzed hydrolysis of 1 was measured directly by monitoring the decrease in 
absorbance at 360 nm. Likewise, initial velocities of SbAD-catalyzed condensation of pyruvate 
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with cinnamaldehyde and either inhibitor 4 or 7 was also monitored directly. All fitting was done 
in GraphPad Prism 5. The equations used to fit steady state kinetic data by non-linear regression 
were as follows: 
Non-competitive Y=(Vmax*X/(1+[I]/Ki))/(X+KM) 
Uncompetitive VmaxApp=Vmax/(1+I/AlphaKi) 
KMApp=KM/(1+I/AlphaKi) 
Y=VmaxApp*X/(KMapp+X) 
Mixed VmaxApp=Vmax/(1+I/(Alpha*Ki)) 
KMApp=KM*(1+I/Ki)/(1+I/(Alpha*Ki)) 
Y=VmaxApp*X/(KMApp + X) 
Competitive KMObs=KM(1+[I]/Ki) 
Y=Vmax*X/(KMObs+X) 
 
Steady State Mutant Kinetics 
Assays were done with 0.1 µM SbAD and mutants in 50 mM Bis-Tris pH 6.5 on a TgK DX2 
stopped-ﬂow instrument. The initial velocity of SbAD-catalyzed hydrolysis of 3 and aldolase-
dehydratase activity of 1 and 2 were measured directly by monitoring in absorbance at 360 nm. 
The kcat and KM values were determined from the initial velocity data using the equation v0 = 
Vm[A]/(KM + [A]), where [A] is the concentration of the aldehyde or benzylidenepyruvate 
substrate, v0 is the initial velocity, Vm is the maximal velocity, and KM is the Michaelis constant. 
Fluorescence Titration for KD Determination 
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 All work was done on a Hitachi F-4500 fluorimeter with a fluorescence cuvette in 
triplicate. The cuvette was rinsed between each use. 1.0 ‒ 3.0 µM SbAD WT, and mutants were 
titrated with substrate at λex 280nm for tryptophan excitation and monitored from 300 ‒ 600 nm 
for λem in quenching for tryptophan with substrate. A plot of fractional saturation versus 
concentration was fitted against a model equation (Y = X / (X + KD)) to determine KD. SbAD WT 
with sodium pyruvate (2) and 4-nitrocinnamaldehyde was done in 100 mM MOPS pH 7.0, and 
cinnamaldehyde (1) in 50 mM BIS-Tris pH 6.8. All fitting was done in OriginPro 2016 Student 
Version 64Bit and Kaleidagraph. 
pH Rate Profile 
A tri-buffer system was used containing 100 mM sodium acetate, MES, and TRIS for pH 
ranging from 4.0 to 9.0 by 0.5 intervals. All kinetic assays were conducted in triplicate at 25 °C 
with 0.1 µM SbAD WT and E84Q on a TgK DX2 stopped-ﬂow instrument. The initial velocity of 
SbAD-catalyzed aldolase-dehydratase activity of 1 and 2 were measured directly by monitoring 
in absorbance at 360 nm. The kcat and KM values were determined from the initial velocity data 
using the equation v0 = Vm[A]/(KM + [A]), where [A] is the concentration of the cinnamaldehyde, 
v0 is the initial velocity, Vm is the maximal velocity, and KM is the Michaelis constant. The plots of 
log(Initial Rate) versus [H+] to determine pKa from the equation log(C / (1 + (K2/H) + (H/K1))), 
where K1 and K2 are the dissociation constants for the ionization of groups that must be 
unprotonated and protonated, respectively, for catalysis, and C is the pH-independent value of 
the kinetic parameter of interest 31.  
Differential Scanning Calorimetry (DSC) 
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 DSC was performed on a TA Instruments Nano DSC with 9 ‒ 12 mg/mL enzyme in 100 mM 
MOPS pH 7.0. Experiments were done in triplicate after an initial run to obtain an idea of 
appropriate temperature range. 
Crystallization, Structure Determination, and Model Refinement 
SbAD Y252F was previously crystallized as described in Chapter II. Crystals of SbAD Y252F 
were soaked in 5 mM 4NCP for two hours before being flash cooled. Molecular replacement from 
the SbAD WT (PDB ID 4ZBO) was used to determine phases.  
Size Exclusion Chromatography 
 The solution molecular weight of SbAD WT, D107N, D109A, and D109N was estimated by 
gel filtration chromatography using a Sephadex S-200 analytical column on an AKTA FPLC. The 
column was calibrated using standard proteins including equine heart cytochrome C (12.4  kDa), 
bovine erythrocyte carbonic anhydrase (29 kDa), bovine serum albumin (66 kDa), yeast alcohol 
dehydrogenase (150 kDa), and sweet potato –amylase (200 kDa). To define the standard curve, 
each protein was dissolved at 10mg/mL in the running buffer and the separation was performed 
on 500 μL of the standard mixture at 25 °C. A sample of the SbAD variants (10 mg/mL) was run 
immediately afterward using the same column and identical conditions. 
 
4.3 Results and Discussion 
No intermediates were detected from the progress curves obtained from steady state 
kinetics, which is logical because it is cumulative of all the steps in a mechanism. Single turnover 
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transient kinetics were done to detect, if any, intermediates could be detected in the reaction. 
Excess SbAD and pyruvate with limiting cinnamaldehyde revealed an increase and concomitant 
decrease at 430 nm, previously unseen in other UV-Vis analyses (Figure 21). The appearance of 
cinnamylidenepyruvate, the product of the reaction, can be monitored at 340 – 360nm.  
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 Figure 21. 
Cinnamylidenepyruvate 
product formation 
occurs at 360 nm. There 
is a rise at 430 nm at the 
same time as product is 
released. The decrease 
and steady state of the 
longer wavelength 
indicate an intermediate 
decrease, and a slow 
decrease in the steady 
state as substrate 
(cinnamaldehyde) is 
used. 
 
 
 
Figure 22. 
Cinnamylidenepyruvate 
product decreases 
drastically at 350 nm 
while an increase at 430 
nm occurs. Once steady 
state is reached for 350 
nm, it remains linear, 
while 430 nm indicates 
an intermediate with 
the decreased slope. 
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The reversible reaction was also monitored with excess SbAD and limiting 
cinnamylidenepyruvate. Again the rise and subsequent fall at 430 nm occurred (Figure 22).  
The longer wavelength spectra indicate a more conjugated intermediate, which is proposed in 
Scheme 7. Inspection at 430 nm revealed a burst of absorbance before attainment of the steady 
state rate, as observed in Table 5.  
Table 5. Burst kinetics were observed with saturating pyruvate (200mM) and 4-nitrocinnamaldehyde (500 µM). 
y = -A exp(-kt) + mx + C 
[SbAD WT] (µM) 1.25 2.5 5.0 
Amplitude (A) 0.029 ± 0.002 0.063 ± 0.001 0.136 ± 0.003 
Burst rate (k, s-1) 262.4 ± 10.7 206.8 ± 2.9 237.1 ± 3.0 
Steady state rate (m, A s-1) 0.002 ± 1.0 x 10-4 0.004 ± 1.0 x 10-4 0.009 ± 1.8 x 10-4 
The amplitude doubles as the enzyme concentration doubles, confirming the reaction observed 
is enzyme catalyzed, and not spurious in solution, likewise with the steady state rate. The burst 
rate does not appear to vary with enzyme concentration. This indicates that a rate limiting step, 
likely product release, is building up before attainment of the steady state is reached. 
Single turnover transient kinetics were repeated: it was anticipated that in order for 
cinnamaldehyde to bind and react, pyruvate needed to be bound to the active site lysine first. As 
 
Scheme 7. Proposed intermediate at 430 nm. 
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illustrated in Figure 23, two syringes of the stopped flow apparatus were filled with various orders 
of SbAD and substrate. If cinnamaldehyde were to bind first, it appears that pyruvate would not 
be able to fit into the narrow active site tunnel. Based on the data from Figure 23, that clearly did 
not occur, and the reaction proceeded whether or not cinnamaldehyde was incubated with 
enzyme. 
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Figure 23. Order of addition reactions were used to determine if there was an observable binding order between pyruvate 
and cinnamaldehyde for SbAD WT. The syringe schemes represent the syringes from stopped flow, located above the data. 
The left panel in green is from 360 nm, following product formation. The right panel, with blue traces, monitored 430 nm, is 
intermediate formation and loss. In both traces, the dashed black line is the fit to the data, interpretation of which is 
underneath the figures. 
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 Based on all of the order of addition experiments in Figure 23, there is no dependence on 
concentration for kobs. This implies that if there are any concentration dependent steps, they 
occur during the dead time of the stopped flow instrument, or that the substrate-dependent 
binding step is invisible. There is an approximately 20 sec-1 advantage to having SbAD incubated 
with pyruvate previous to cinnamaldehyde mixing than when SbAD is by itself or combined with 
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cinnamaldehyde before pyruvate 
addition, suggesting that it is more 
efficient to have pyruvate bound first, 
before cinnamaldehyde. The reaction of 
SbAD with CMP and SbAD mixed against 
pyruvate and cinnamaldehyde had the 
about the same kobs,1, showing that the 
reversibility of SbAD occurs on a similar 
time scale. Interestingly, the turnover number for steady state kinetics at room temperature was 
28.3 ± 0.4 sec-1 in 50 mM BIS-Tris pH 6.5, whereas the stopped flow values were recorded at 5 °C 
in the same buffer, but at pH 7.0. Temperature has an effect on the reaction rate, the discrepancy 
in rates from temperature likely has to do with steady state being the culmination of all steps in 
the reaction, whereas single turnover is recorded for transient species. Overall, the synthetic 
direction with incubated pyruvate provides the reaction with a kobs of 65 sec-1, and about 45 sec-
1 if SbAD is alone, then mixed with substrates, or if SbAD is incubated with cinnamaldehyde 
before reacting with pyruvate. The retro-aldol 
breakdown is about 45 sec-1 as well.  
Though the single turnover order of 
addition kinetics hinted that pyruvate may be more 
efficient if bound first, it didn’t answer the question 
of whether or not pyruvate has to bind first for a 
reaction to occur with SbAD. Inhibition kinetics 
Table 6. KD values for cinnamaldehyde (1) and 
pyruvate (2), compared to substrate analogs 4-7 as 
determined by fluorescence titration. 
Compound KD 
Cinnamaldehyde (1) 58.18 ± 6.74 µM 
4-phenyl-3-buten-2-one (7) 42.34 ± 12.78 µM 
Pyruvate (2) 6.48 ± 0.59 mM 
2,3-butanedione (4) 12.24 ± 1.67 mM 
Oxamate (5) 97.04 ± 10.60 mM 
Glyoxylate (6) > 500 mM 
 
 
Scheme 8. Inhibitors tested for SbAD. 
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addressed this question by competing substrate analogs with pyruvate and cinnamaldehyde. The 
candidate substrates are shown in Scheme 8, and KD values in Table 6. The substrate analog for 
cinnamaldehyde (1) was 4-phenyl-3-buten-2-one (7), as the nucleophilic attack by the pyruvate 
enamine on the ketone of 7 cannot occur due to the added bulk of the methyl group. Other 
options for sodium pyruvate were available, however 2,3-butanedione (4) had the most similar 
binding constant. This suggests that the methyl group of pyruvate may also be important to 
binding. The best inhibition models and the associated Ki values are given in Table 7. 
Table 7. Inhibition kinetics were used determine the order of addition of pyruvate and cinnamaldehyde in the active site of 
SbAD. 
Compound of interest Varying inhibitor Inhibition model Ki 
pyruvate 2,3-butanedione Non-competitive 36.38 ± 2.45 mM 
cinnamaldehyde 2,3-butanedione Mixed 8.12 ± 1.66 mM 
pyruvate 4-phenyl-3-buten-2-one No Effect ‒ 
cinnamaldehyde 4-phenyl-3-buten-2-one Competitive 258.6 ± 77.39 µM 
Based on Table 7, it appears that pyruvate likely binds first, as 4-phenyl-3-buten-2-one has no 
effect on catalysis when pyruvate is varied. In addition, pyruvate was surprisingly non-
competitive with 2,3-butanedione, suggesting that although cinnamaldehyde or 2,3-butanedione 
may already be in the active site, pyruvate is still able to bind. Cinnamaldehyde was competitive 
with 7, which shows that after pyruvate is bound, the aldehyde acceptor is needed next for 
catalysis, consistent with the proposed mechanism. 
 Kinetic isotope effects were also done to tease apart the mechanism of SbAD. 1H3 
pyruvate and 2H3 pyruvate were observed via single turnover to see the effect deuterated 
substrate had on the transient kinetics with cinnamaldehyde going in the synthetic direction to 
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form cinnamylidenepyruvate (CMP). The data are shown in Figure 24, where the end points have 
been artificially moved to match one another for comparison purposes. The data at 360nm for 
1H3 (Figure 24 A, green) is best modeled by a two exponential fit, whereas the data with 2H3 
(Figure 24 A, blue) shows a lag, and then appears to speed up such that only the second kobs from 
1H3 is comparable. These results are consistent with a secondary, inverse effect, consistent with 
the proposed mechanism where the enamine goes from sp2 to sp3 during nucleophilic attack on 
the aldehyde substrate. The 430 nm data (Figure 24 B), however, show a primary effect, as the 
rates for 2H3 (Figure 24 B, blue) are slower in kobs,1 and kobs,2. The fits do not agree well with the 
 
Figure 24. KIE of 1H3 and 2H3 of pyruvate, where 1H3 is in green with a dashed fit line, and 2H3 is in blue with a solid fit line. 
Underneath are the kobs associated with 360 and 430 nm. 
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data for 2H3 pyruvate (Figure 24 B, blue), suggesting that there is more going than can be modeled 
by a simple two exponential equation.  
 In addition to transient kinetics, steady state kinetics were also done with KIE. First, the 
reaction of 1 and 2H3 pyruvate in the synthetic direction was studied to see if there would be any 
difference in the steady state rates, Table 8. 
The values are largely equivalent, which is 
not surprising, as the steady state rate is all 
of the accrued steps in the reaction. In the 
transient kinetic experiments, after 1 
second, largely equivalent kobs are obtained. We also analyzed the reaction for a solvent isotope 
effect. Phosphate buffer was used, as it could be controlled for pH via the Henderson-Hasselbalch 
equation rather than titrated to pH with deuterated HCl or NaOH. The results for the reaction in 
the catabolic direction, of 3 going to 1 and 2, in proteo- and deutero buffer are seen in Table 9. 
In this preliminary experiment, the kcat shows a clear difference between the reaction rates 
between the proteo and deuterated solvent, suggesting the importance of water in the retro-
aldol cleavage reaction. 
Table 8. Steady state kinetics comparing saturating 1H3 and 2H3 
pyruvate with cinnamaldehyde, monitored at 360 nm at 25 °C. 
Reactions were done in triplicate. 
 1H3 pyruvate 2H3 pyruvate 
kcat,cinn (sec-1) 
KM,cinn (µM) 
9.0 ± 1.1  
23.0 ± 8.1 
10.4 ± 1.0 
40.1 ± 6.6 
kcat,cinn/KM,cinn (M-1sec-1) 3.9 x 105 2.6 x 105 
Table 9. Steady state kinetics comparing saturating 1H and 2H phosphate buffer with 
CMP catalysis, monitored at 360 nm at 25 °C. Reactions were done in triplicate. 
 1H 50 mM PO4 pH 7.0 2H 50 mM PO4 pD 7.4 
kcat,cinn (sec-1) 
KM,cinn (µM) 
0.35 ± 0.01  
18.8 ± 2.5 
0.06 ± 0.001 
14.3 ± 1.4 
kcat,cinn/KM,cinn (M-1sec-1) 1.9 x 104 4.2 x 103 
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Another important component of 
elucidating the mechanism of SbAD has been 
mutant analysis. Point mutations were 
generated at select positions within the active 
site, then these SbAD variants were 
characterized by steady state kinetics, 
fluorescence titration of substrates to test 
effects on binding, and X-ray crystallography. 
Figure 25 illustrates the residues that were 
mutated in the active site. We hypothesized 
that a change of Try82, a component of the 
carboxylate binding site, would decrease kcat and increase KM, as it does contribute a potential 
hydrogen bonding interaction to the pyruvate carboxylate group. We also hypothesized that 
mutating the active site lysine would result in an inactive enzyme. Likewise, if Glu84 is the only 
acid/base catalyst, there should be no activity if it is mutated to a residue that cannot play this 
role. Tyr252 was the residue bound to the same conserved water in both the formate- and 
pyruvate-bound structures. We postulated that Tyr252 might be involved in binding the incoming 
aldehyde substrate and/or orienting it for attack by the enamine. Mutating Tyr252 to Phe 
removes any potential non-covalent interaction with the aldehyde and should have a noticeable 
effect on catalysis. Lastly, Gln118 was mutated to Asn. Another Family V enzyme, Swit_4259 
(Swit; see Chapter V), naturally has Asn at this position, and appears differ from SbAD in terms of 
its function. We speculated that mutating Gln118 to Asn would result in an SbAD variant that  
 
Figure 25. Active site residues of interest that were mutated 
to observe the effect of steady state kinetics. This is the 
active site pyruvate-bound structure seen in Chapter II. 
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behaved more like Swit. Double mutants were also created in an effort to detect cooperative 
residues. Tyr82Phe/Tyr252Phe and Tyr82Phe/Glu84Gln could affect binding and catalysis. If that 
is the case for the double mutants, the steady state kinetics should have lower kcat and higher KM 
than the individual mutants. Glu84Gln/Tyr252Phe was based on two possible key catalytic 
residues in the active site, and are predicted to render the enzyme inactive if they are both 
needed for catalysis. The effects of the mutations on the steady state parameters and relevant 
binding constant(s) in the synthetic direction with cinnamaldehyde and pyruvate are given in 
Table 10 and 11, respectively. All 
experiments were performed 
with near-saturating pyruvate 
(50 mM) at 25 °C. It is clear from 
Table 10 that Glu84 is not the 
sole acid/base catalyst, as there 
is only a 10-fold reduction in 
activity in the Glu84Gln mutant. 
Table 10. Steady state kinetics for active site mutants of SbAD at 25°C. 
SbAD kcat,cinnamaldehyde (sec-1) KM,cinnamaldehyde (µM) kcat/KM (M-1 sec-1) 
WT 23.00 ± 0.38 38.43 ± 2.03 5.98 ± 0.33 x 105 
E84Q 2.52 ± 0.02 38.88 ± 1.10 6.48 ± 0.19 x 104 
Q118N 0.214 ± 0.006 52.86 ± 5.20 4.05 ± 0.41 x 103 
K122M No Activity 
Y252F 1.45 ± 0.01 5.42 ± 0.67 2.67 ± 0.33 x 105 
Y82F Y252F 1.20 ± 0.02 7.22 ± 0.75 1.66 ± 0.17 x 105 
E84Q Y252F No Activity 
Table 11. KD values for SbAD WT and active site mutants 
SbAD Sodium Pyruvate (mM) Cinnamaldehyde (µM) 
WT 6.48 ± 0.59 58.18 ± 6.74 
Y82F 1.87 ± 0.27 81.83 ± 8.72 
E84Q 5.28 ± 1.06 56.58 ± 3.24 
Q118N 5.36 ± 1.01 73.89 ± 6.66 
K122M 11.29 ± 1.79 87.29 ± 9.57 
Y252F 5.50 ± 0.86 41.74 ± 2.98 
E84Q Y252F 54.69 ± 5.99 93.24 ± 9.25 
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The Glu118Asn shows a dramatic 
decrease in kcat, while the KM is 
largely unaffected, suggesting 
that is plays a catalytic role, at 
least indirectly, and is not there 
solely for substrate binding. As 
expected, Lys122Met had no 
activity because there is no amine available for the Schiff base chemistry. The Tyr252Phe variant 
exhibited a tighter KM than WT, however its kcat was slower. This may be due to the inability to 
properly orient the aldehyde group for catalysis. All of the values are from steady state kinetics, 
however, which do not articulate if the activity is due to binding or catalysis. Tyr82Phe was not 
shown in Table 10 because it was measured with different substrates and at a different 
temperature. Table 12 compares WT and Tyr82Phe reacting with 50 mM pyruvate and varying 
concentrations of 4-nitrocinnamaldehyde at 4°C in 100 mM MOPS pH 7.0. The values for the 
reverse reaction, breakdown of 4-nitrocinnamylidenepyruvate (4NCP) under the same conditions 
Table 13. Steady state kinetics for active site mutants of SbAD in the catabolic direction. 
SbAD kcat,CMP (sec-1) KM,CMP (µM) kcat/KM (M-1 sec-1) 
WT 1.14 ± 0.05 15.42 ± 1.95 7.39 ± 0.99 x 104 
E84Q 0.56 ± 0.02 27.13 ± 1.91 2.06 ± 0.16 x 104 
Q118N 0.37 ± 0.03 16.57 ± 3.33 2.23 ± 0.48 x 104 
K122M No Activity 
Y252F 0.74 ± 0.02 4.82 ± 0.43 1.53 ± 0.14 x 105 
Y82F Y252F 0.53 ± 0.04 26.42 ± 4.56 2.0 ± 0.38 x 104 
E84Q Y252F No Activity 
Table 12. Comparison of SbAD WT and Y82F in steady state kinetics at 4 °C with 
4-nitrocinnamaldehyde (4NC) and 4-nitrocinnamylidenepyruvate (4NCP). 
 SbAD WT SbAD Y82F 
kcat,4NC (sec-1) 6.3 ± 0.1 13.9 ± 0.3 
KM,4NC (µM) 2.9 ± 0.7 11.8 ± 1.0 
kcat/KM,4NC (M-1 sec-1) 2.2 ± 0.5 x 106 1.2 ± 0.1 x 106 
kcat,4NCP (sec-1) 1.9 ± 0.5 1.9 ± 0.2 
KM,4NCP (µM) 82.3 ± 29.1  75.1 ± 9.2 
kcat/KM,4NCP (M-1 sec-1) 2.3 ± 1.0 x 104 2.5 ± 0.4 x 104 
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are also given. The Tyr82Phe mutant and WT SbAD are almost identical. It appears that Y82 is not 
a necessary part of the carboxylate-binding site, and it plays no discernable catalytic role.  Table 
13, the breakdown direction of cinnamylidenepyruvate (CMP) 3, the mutants largely follow SbAD 
WT. Either the loss of conjugation at 360 nm is occurring from the complete breakdown of 3, or 
it could be that 3 has bound to the enzyme, lost conjugation, but cannot complete the catabolic 
process. 
 The KD values of cinnamaldehyde and pyruvate were measured to more fully understand 
mutations upon substrate binding (Table 11). Based on the activity of Gln118Asn, it was proposed 
that the lack of activity was to do impairment of substrate binding. However, the binding 
constants for both pyruvate and cinnamaldehyde are identical. Therefore, Gln118Asn may play a 
catalytic role, perhaps keeping the substrate carboxylate for substrate assisted catalysis, similar 
to sialic acid aldolase, mentioned in Chapter II 32. Alternatively, Glu118 might keep another 
catalytic residue in position for catalysis. The mutants with no activity in steady state kinetics also 
have KD values essentially identical to WT. The KD of Lys122Met has only about doubled in value, 
suggesting that the carboxylate-binding site is responsible for the bulk of pyruvate binding, at 
least, and that the measured values are not dominated by the covalent attachment to Lys122. In 
the Glu84Asn/Tyr252Phe double mutant, the KD for pyruvate is nearly 10-fold higher, though the 
KD for cinnamaldehyde is about the same. The KD for 4NCP is not in Table 11 because Lys122Met 
was used to prevent catalysis from occurring. 4NCP with Lys122Met was 14.44 ± 3.52 µM. 
Lys122Met was a reliable source to approximate KD as its values with pyruvate an 
cinnamaldehyde resembles SbAD WT. 
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 Most of the kinetics were done between pH 6.5 and 7.0, however a formal pH rate profile 
remained to be done. The goal was to find approximate pKas for the active site residues that 
could be participating in the reaction. The results for the WT enzyme are shown in Figure 26 A. 
The results from fitting WT were pKas of 4.09 and 8.95. The fit does not represent what has been 
measured, indicating that there are more complex reactions going on than simple proton 
transfer. The 4.09 pKa indicated that perhaps the Glu84 mutant was the largely responsible 
acid/base catalyst, so Glu84Gln also had the pH rate profile done. The pKas from Glu84Gln were 
4.37 and 7.89. It was expected to show different activity if E84 was the only acid/base catalyst, 
but the fit looks like WT, thereby concluding again that there are more complicated reactions 
occurring than a pH rate profile can answer. 
 
During the mutagenesis process, it was proposed that E84Q could be impaired due to 
perturbation of the structure. Therefore, DSC was done to test the stability of this mutant (Figure 
27). 
 
Figure 26. pH rate profile for SbAD WT (A) and SbAD E84Q (B). Both follow the same overall shape from fitting, concluding 
that E84 is not the sole acid/base catalyst in the reaction, but does indeed react more slowly than WT. 
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A clear difference is seen for the Tm of Glu84Gln compared to WT, as seen in Table 14. Since the 
ΔH° values derived from DSC are smaller than the van’t Hoff analysis within the error estimates, 
it appears that there is a two-state transition between folded and unfolded SbAD. There is no 
information based on ΔHvH to determine if the proteins formed oligomers before aggregation or 
intermediates on the way to unfolding. 
All of the values quoted thus far are from 
steady state kinetics, however, which makes it 
difficult to confidently assess each residue’s role in 
SbAD catalysis. Select active site mutants were 
looked at by transient kinetics under single 
turnover conditions. At 430 nm (Figure 28), it is 
Table 14. Results and analysis of DSC for SbAD WT and active site mutant, where ΔHvH is the van’t Hoff analysis. 
SbAD Tm (°C) ΔH (kJ mol-1) ΔS (kJ mol-1 K-1) ΔHvH (kJ mol-1) 
WT 53.4 ± 0.6 241.2 ± 37.0 0.74 ± 0.1 654.3 ± 55.1 
E84Q 45.4 ± 0.1 62.2 ± 6.0 0.20 ± 0.0 666.8 ± 11.2 
 
Figure 27. DSC for WT and E84Q. The raw data is compared to the van’t Hoft analysis. 
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Figure 28. 50 µM 4NCP reacted with 10 µM SbAD WT, 
Y252F, and E84Q in 50 mM BIS-Tris pH 6.5, 5 °C. 
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apparent that, while the intermediate begins to decay in the WT enzyme by about 100 
milliseconds, it remains stable in Tyr252Phe well past 1 second (see Appendix). The Glu84Gln 
mutant appears to be completely dead on this time scale, but the reaction is occurring as 
evidenced by the steady state kinetics (see above).  The stability of the proposed Schiff base 
intermediate in the Tyr252 active site suggested that it would be a good candidate for 
crystallization.  
 
 
 
 
The condensation product was trapped in all four active sites, with waters excluded from 
the active site tunnel, as seen in Figure 29. The red loop marks the surface of the protein, and 
mouth of the active site. On either side of the active site loop, there are two openings to this 
narrow, funnel-shaped active site, and the Tyr252Phe mutant is visible (red label in Figure 29). 
Aside from the carboxylate-binding site, the rest of the active site is hydrophobic and binding of 
Table 15. Crystallographic Data Collection and Model Refinement Statistics. 
 SbAD Y252F·4NCP 
  
resolution (Å) (last shell)a 50.00-1.90 (1.97-1.90) 
completeness (%)a 99.8 (99.4) 
Rmerge (%)a,b 0.110 (0.494) 
multiplicity 19.8 (4.0) 
⟨I/σ(I)⟩a 7.0 (6.0) 
Model Refinement 
    
Rcryst (Rfree) 0.166 (0.192) 
average B factor (Å2)c 
               protein atoms 
               solvent 
 
22.2 
32.9 
root-mean-square deviation 
               bond lengths (Å) 
               bond angles (deg) 
 
0.005 
0.953 
Ramachandran statistics 
(favored/allowed/outliers) 
 
98.2/1.8/0 
aValues in parentheses apply to the high-resolution shell indicated in the resolution row.  
bR = ∑(||Fobs| − scale ×| Fcalc||)/∑|Fobs|. cIsotropic equivalent B factors, including the 
contribution from TLS reﬁnement. 
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the product is ruled by Van der Waal interactions. It may be that this complex is trapped because 
there is no hydrogen bonding group or water to facilitate hydration of the double bond. Thus, 
Tyr252 would appear to have a catalytic role. The torsion angles of the bound product (Figure 30 
and Table 16) are also intriguing. 
Table 16. Values of the dihedral were averaged over the four 
active sites in the crystallographic asymmetric unit.  
Torsion angles Average (degrees) Range (degrees) 
1 169.9 ± 3.0 166.4 – 173.3 
2 163.7 ± 5.1 156.2 – 167.8 
3 164.8 ± 2.8 161.6 – 167.9 
4 82.4 ± 12.8 72.2 – 100.5 
5 175.2 ± 2.5 171.5 – 176.8 
6 34.4 ± 13.1 19.1 – 48.0 
 
Figure 29. Crystal structure of SbAD Y252F with 4NCP bound in the active site. 2|Fo|-|Fc| electron density is in magenta 
and SA omit electron density is in green. Both are contoured at 1.2σ. 
 
 
Figure 30. Torsion angles of the 4NCP complex. 
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The torsion angle labeled as 4 is near 90 °, suggesting that it contributes to substrate 
destabilization by breaking up the conjugation from the ring system, and making it easier to add 
water across the double bond that would lead to an aldol intermediate before retro-aldol 
cleavage. The Schiff base complex with 4NCP is the intermediate thought to be seen at 430nm. 
If the conjugation is broken like this when the protein is in solution, then this Schiff base should 
not be seen spectroscopically. 
 In addition to active site mutants, protomer interface mutants were also explored. They 
were initially predicted to have perturbed pKa values due to Theoretical Microscopic Titration 
 
Figure 31. Size exclusion results. Each trace has been artificially shifted by 100 mAu for clarity.  
105 
 
Curves (THEMATICS)  and Partial Order Optimum Likelihood (POOL) analysis 33.  THEMATICS uses 
the sequence of a protein in a crystal structure to search for ionizable residues, along with the 
probability that a residue participates in binding or catalysis from POOL to determine 
hypothetical pKas. The program accurately predicted the perturbed Lys122 in the active site, 
however it also suggested Asp107 and Asp109 also have perturbed pKa values. As a means to 
explore this possibility, Asp107 was mutated to Asn, and Asp109 to Asn and Ala. All three mutants 
were analyzed by gel filtration, which indicated the presence of significant aggregation (Figure 
31). All mutants and WT were produced, then incubated at 4 °C for 24 hours before gel filtration 
analysis. The Asp109Asn variant showed multiple peaks in the chromatogram, indicating that it 
exists as aggregate, as well as a mixture of other oligomeric states. The molecular weight of the 
species in the first peak was estimated to be 74.6 kDa, between a dimer and trimer, while the 
second peak appears to be a dimer. Attempts were made to determine the structure of the 
Asp109Asn variant, however the crystals were poor and did not diffract well enough. 
Characterization of  Asp109Asn by DSC shows that it is much less stable than WT and Glu84Gln 
(Figure 31). 
 
Figure 32. DSC for WT and D109N. The raw data is compared to the van’t Hoft analysis. 
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Again, the van’t Hoff analysis is larger, within error, of the calculated of ΔH as determined by 
experiment, suggesting a simplified two-state model of either the protein is folded, or not. The 
steady state kinetics and selected binding constants shed light on to the instability. Table 18 
compares the steady state kinetics of the protomer mutants with cinnamaldehyde (1) and 
saturating pyruvate (2) compared to WT, as well as the breakdown of cinnamylidenepyruvate (3). 
Asp107Asn surprisingly had a higher turnover number than WT. It is not entirely clear why this 
is, as modeling in Asn at the 107 position does not appear to disturb the hydrogen bonding 
distances. Asp109Ala, and more to Asp109Asn, have slower kcat and bigger KM in the synthetic 
direction, possibly due to a slight possible conformational shift. 
Asp109Ala behaves much like WT, the truncated residue does not greatly affect its steady state 
values. Overall, Table 18 indicates that the protomer mutant Asp109Asn is an inactive protein, 
Table 17. Results and analysis of DSC for SbAD WT and protomer mutant, where ΔHvH is the van’t Hoff analysis. 
SbAD Tm (°C) ΔH (kJ mol-1) ΔS (kJ mol-1 K-1) ΔHvH (kJ mol-1) 
WT 53.4 ± 0.6 241.2 ± 37.0 0.74 ± 0.1 654.3 ± 55.1 
D109N 39.6 ± 0.5 54.5 ± 10.2 0.17 ± 0.0 709.1 ± 137.8 
Table 18. The anabolic and catabolic steady state kinetics of protomer interface mutants. 
SbAD kcat,cinnamaldehyde 
(sec-1) 
KM,cinnamaldehyde 
(µM) 
kcat/KM (M-1 sec-1) kcat,CMP (sec-1) KM,CMP (µM) kcat/KM (M-1 sec-1) 
WT 23.00 ± 0.38 38.43 ± 2.03 5.98 ± 0.33 x 105 1.14 ± 0.05 15.42 ± 1.95 7.39 ± 0.99 x 104 
D107N 47.89 ± 0.81 27.62 ± 1.67 1.73 ± 0.11 x 106 1.82 ± 0.03 11.44 ± 0.66 1.59 ± 0.10 x 105 
D109A 5.86 ± 0.12 56.15 ± 3.29 1.04 ± 0.06 x 105 0.64 ± 0.03 19.70 ± 2.54 3.25 ± 0.45 x 104 
D109N 0.151 ± 0.006 11.09 ± 2.19 1.36 ± 0.27 x 104 0.33 ± 0.02 11.98 ± 1.68 2.75 ± 0.04 x 104 
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such that the concentration of active enzyme is much less than the concentration of the total 
enzyme since the KM values are equivalent to WT, and kcat is slower than WT. 
4.4 Conclusions 
 The proposed mechanism of Figure 20 has been confirmed throughout this chapter as a 
likely method of catalysis. Pyruvate binds to the enzyme first, for a sequential, ordered reaction. 
An imine with pyruvate and the active site lysine, then attacks the aldehyde carbon from the 
nucleophilic enamine.   The Schiff base with product bound is proposed to be observed at 430nm, 
however the crystallographic data from Tyr252Phe suggests the break in conjugation with the 
ring system would result in lack in observable absorbance at that longer wavelength. It is possible 
torsion aids breakdown in the retro-aldol process, and was slow enough to occur from the mutant 
that it was able to be trapped. Hydrolysis of product from the enzyme is likely to be rate limiting 
based on the burst kinetics and single turnover work. The protomer interface mutants show 
structural instability and do not point to cooperativity in the enzyme. SbAD demonstrates 
aldolase-dehydratase ability with the ADC overall fold, and illustrates the subtle differences 
between true ADCs and MppR by catalyzing different reactions, but still retaining a Schiff base 
mechanism. 
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CHAPTER V: STRUCTURAL AND FUNCTIONAL ANALYSIS OF SWIT_4259 
5.1 Introduction 
Some of the most dangerous and wide-spread pollutants on earth are aromatic 
hydrocarbons like dioxins, polychlorinated biphenyls (PCBs), herbicides, and pesticides. These 
compounds are recalcitrant in the environment due to their low solubility in water, tendency to 
adsorb to solids, and dissimilarity to naturally occurring compounds (e.g. halogenation). Thus, 
there is significant interest in natural or engineered bioremediation pathways capable of 
metabolizing these contaminants to harmless organic compounds 1. Some microorganisms, 
particularly bacteria, have evolved the ability to consume aromatic hydrocarbons as carbon and 
energy sources 2-4. Sphingomonas wittichii RW1 is a Gram-negative bacterium that was first 
isolated from contaminated sediments in the Elbe River in Germany, and it is known for its ability 
to degrade a wide variety of aromatic substrates, including dioxins and PCBs 5, 6. The S. wittichii 
RW1 genome thus contains a large number of aromatic hydrocarbon catabolism gene clusters, 
only a handful of which have been characterized. 
Relative to other species, the S. wittichii genome is enriched for TonB-dependent 
receptors (TDRs; COG1629), dehydrogenases (COG1028), and phenylpropionate dioxygenases 
(COG4638) 7. In fact, the S. wittichii RW1 genome contains the most TonB-dependent receptors 
of any genome sequenced to date 8. This is interesting, because the TonB system is normally 
associated with uptake of iron-bound siderophores, but the majority of TDR genes in S. wittichii 
RW1 are not in operons associated with iron transport. TonB-dependent receptors have been 
implicated in the transport of other compounds, including sugars 9, alginate 10, and aromatic 
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hydrocarbons (AH) 11. This strongly suggests that many of the TDR-containing gene clusters in S. 
wittichii may actually be cryptic AH-degrading operons. 
One of these TDR-containing, putative AH-degrading gene clusters in S. wittichii (Figure 
33) is particularly interesting for its inclusion of an acetoacetate decarboxylase-like enzyme, 
Swit_4259. Swit_4259 (SwADC) has 18% sequence identity to the prototypical Clostridium 
acetobutylicum acetoacetate decarboxylase (AAB53232), placing it in the acetoacetate 
decarboxylase-like superfamily (ADCSF). The ADCSF is a poorly-characterized group of enzymes 
with significant diversity in both substrate and reaction specificities 12. The characterized 
acetoacetate decarboxylases (e.g. the C. acetobutylicum enzyme) comprise the majority of 
ADCSF sequences and are designated Family I. The reactive lysine residue that forms a Schiff base 
intermediate is conserved in all but one ADCSF family (Family II). SwADC belongs to ADCSF Family 
V, whose members, based on gene context, are primarily involved in secondary metabolism.. 
MppR from Streptomyces hygroscopicus 13 was shown to catalyze both aldol condensation 
followed by dehydration of pyruvate and imidazole-4-carboxaldehyde as well as cyclization of 4-
hydroxy-2-keto arginine to produce 2-keto-enduracididine 12, as seen in chapter II, though it is 
not known if these activities are physiologically relevant. Herein we describe the tertiary 
structure of SwADC as well as a preliminary characterization of its enzymatic activity. 
 
 
Figure 33. Gene context of S. wittichii Swit_4259. 
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5.2 Materials and Methods 
Cloning, expression, and purification of SwADC.  
The gene at locus Swit_4259 encoding the protein identified by GenBank accession code 
YP_001264737 7 was optimized for expression in E. coli and synthesized by GenScript (Piscataway, 
NJ). The SwADC gene was amplified using oligonuculeotide primers SwADC-pSUf (5’-
GGTCTCAAGGTATGGCTGGTGCTACGCAT-3’), which introduces a Bsa I site, and SwADC-pSUr (5’-
GCTCTAGATCATCACATACGCAGGGATTCCA-3’), which introduces a stop codon and Xba I site. 
Purified PCR products were digested with Bsa I and Xba I and ligated into the pE-SUMOkan 
expression vector (LifeSensors Inc, Malvern, PA) to generate pSUMO-SwADC. This plasmid 
expresses SwADC with His6-tagged small ubiquitin-like modifier (SUMO) fused to the N-terminus 
14.  The sequence of pSUMO-SwADC was confirmed by sequencing (GenWiz Inc). BL21 Star (DE3) 
E. coli cells (Invitrogen) were transformed with pSUMO-SwADC and used to inoculate 20 ml 
cultures of Luria-Bertani broth supplemented with 50 μg/mL kanamycin. These starter cultures 
were grown overnight at 37 °C with agitation at 250 rpm. Large-scale cultures (1 L) were 
inoculated from the starter cultures and grown at 37 °C/225 rpm until they reached an OD600 nm 
of about 1.0. The temperature of the incubator was reduced to 25 °C and expression of SwADC 
was induced by addition of Isopropyl β-D-1-thiogalactopyranoside (IPTG) to a final concentration 
of 400 µM.  Cultures were grown overnight at 25 °C. Cells were harvested from the expression 
culture by centrifugation at 7400  g for 30 min and resuspended in Buffer A (25 mM Tris, pH 8.0, 
300 mM NaCl, and 10 mM imidazole) at a rate of 5 mL of buffer per gram of cell pellet. Lysozyme 
was added to a final concentration of 1 mg/mL and the mixture was stored overnight at −20 
°C.  The cell suspension was thawed at RT and allowed to stand for 2 hours, after which 
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deoxyribonuclease I (DNase I, Worthington Biochemical Inc.) was added at a rate of 0.5 mg per 
100 ml of lysate. The lysate was clarified by centrifugation at 39000  g for 45 min.  
Immobilized metal affinity chromatography (IMAC) purification of SwADC was performed in 
two steps. The clarified lysate was applied to a 5 mL HisTrap column (GE Life Sciences, USA) and 
eluted using a 4-step gradient from 0 to 5, 15, 50, and 100% Buffer B (25 mM Tris, pH 8.0, 300 
mM NaCl, and 250 mM imidazole). SwADC eluted primarily at 50% Buffer B (about 125 mM 
imidazole), but a significant amount eluted at the 100% Buffer B step (about 250 mM imidazole). 
The fractions from both elution peaks containing SwADC, as judged by Coomassie-stained SDS-
PAGE gels, were pooled. SUMO protease (LifeSensors Inc) was added to a final concentration of 
about 5 μM  15. The pooled eluate was dialyzed overnight at 4 °C in Buffer C (25 mM Tris, pH 8.0, 
150 mM NaCl) to remove imidazole. In the second step of the purification, the same HisTrap 
column was used to remove the cleaved His6-SUMO fusion partner and the His6-tagged SUMO 
protease. The resulting protein was > 95% pure as judged by SDS-PAGE. A 10 mL HiTrapDesalting 
column (GE Life Sciences, USA) was used to exchange the buffer to 25 mM Bis-Tris pH 7.1 (titrated 
with saturated iminodiacetic acid). The concentration of SwADC was estimated by the 
absorbance at 280 nm (ε280 = 46,660 M-1cm-1). The final yield of purified SwADC was 
approximately 15 mg per L of culture. 
 
Size exclusion chromatography. 
The solution molecular weight of SwADC was estimated by gel filtration chromatography 
using a BioBasic SEC-300 (250mm  4.6 mm) column (Thermo Scientific, USA) on an Agilent 1220 
Compact LC. The mobile phase consisted of 25 mM Tris, pH 8.0, 300 mM NaCl at a flow rate of 
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0.5 ml/min with UV-Vis detection at 280 nm. The column was calibrated using standard proteins 
including equine heart cytochrome C (12.4 kDa), bovine erythrocyte carbonic anhydrase (29 kDa), 
bovine serum albumin (66 kDa), yeast alcohol dehydrogenase (150 kDa), and sweet potato –
amylase (200 kDa). To define the standard curve, each protein was dissolved at 10 mg/mL in the 
running buffer and the separation was performed on 250 μL of the standard mixture at 25 °C. A 
sample of SwADC (6 mg/mL) was run immediately afterward using the same column and identical 
conditions. 
 
Crystallization, data collection and structure determination.  
Preliminary crystallization conditions were identified by sparse matrix screening using the 
Index HT, PEG/Ion HT, and PEGRx HT screens (Hampton Research, USA) at 21 °C. Crystals 
appeared after 1 to 2 days in a variety of conditions. The initial crystals ranged in shape from 
individual rods to what appeared to be bundles of parallel needles. The single, rod-shaped 
crystals diffracted very poorly (dmin ~5 Å), but the "bundles of rods" diffracted to a maximum 
resolution of ~2.0 Å. Diffraction-quality crystals were grown by the hanging-drop vapor diffusion 
method. Drops were formed by mixing 1-2 μl of SwADC (37 mg/ml) in 20 mM phosphate pH 7.0 
with 1 μl of well solution containing 15 % PEG 3,350 and 0.1-0.2M magnesium formate. Crystals 
were flash-cooled by plunging them in liquid nitrogen, without a cryoprotectant. Diffraction data 
were collected from an SwADC crystal at the Life Sciences-Collaborative Access Team, beamline 
21-ID-G equipped with a MAR 300 CCD detector, 50 x 50 µm beam at a wavelength of 0.97857 Å. 
A total of 440 frames were collected from ω = 150 ° to 370 ° with an oscillation range of 0.5 °. 
Diffraction data were integrated and scaled using MOSFLM 16, 17 and SCALA 18 as implemented in 
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the CCP4 suite version 6.3 19. Initial phases were obtained by molecular replacement in PHASER 
20 using the structure of the related ADCSF enzyme MppR (PDB ID 4JM3) as the starting model. 
Iterative rounds of model building and refinement were performed using PHENIX 21, 22 and COOT 
23, 24. Structures were validated using the tools available in the PHENIX package 25, 26. The data 
processing and model refinement statistics are summarized in Table 19.  
 
Acetoacetate decarboxylase activity assay.  
SwADC was assayed for acetoacetate decarboxylase activity by monitoring the disappearance 
of the enolate form of acetoacetate spectrophotometrically at 270 nm (Δε = 24.6 M-1 cm-1) as 
described 27. Reactions were run at 25 °C in 50 mM phosphate buffer, pH 6.5, 2 mM EDTA, on a 
Thermo Scientific Evolution 300 spectrophotometer. The reaction mix containing 20 mM lithium 
acetoacetate in the assay buffer was used as the blank. The reaction was initiated by the addition 
of 10 μM SwADC in the same buffer.  
 
Determination of binding constants.  
There is one tryptophan (Trp24) in the active-site pocket close to Lys122 (about 7 Å between 
Nε of Lys122 and the indole ring of Trp24) which is sensitive to the binding of small molecules in 
the active site. Potential substrates can be titrated to determine the dissociation constant (KD) of 
each compound. The affinity of SwADC for a number of α-keto-acids such as pyruvate and α–keto 
glutarate was tested. Alanine was used as a control compound since it cannot react with the 
active site lysine. The fluorescence signal of Trp excited at 280nm was monitored using TgK 
Scientific stopped flow with 20 μM SwADC or Hitachi F-4500 fluorimeter with 5 µM SwADC and 
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varied substrate concentrations ranging from 1 mM to 1 M, all in in 100 mM Bis-Tris pH 6.5. The 
change in fluorescence signal was also tested using 2-oxo-adipic acid only in 5 mM concentration 
owing to the expense of the compound.  
 
Production of 2-hydroxymuconic acid (2HM) (Scheme 9, 1) 
The synthesis of 2-hydroxymuconic acid was based on that of Metanis et al 28. A solution of 
t-BuOK was prepared by dissolving potassium metal (1.92 g) in t-BuOH (20 mL) and refluxing until 
homogenous. Then, 8 mL of the t-BuOK solution (excess) was combined with 2 mL of ether and 
stirred at 0° C for 15 minutes. A solution of diethyl oxalate was made by mixing 1.35 mL of diethyl 
oxalate and 1 mL of ether. This solution was cooled to 0 °C and added to the t-BuOK solution via 
syringe. The reaction mixture was allowed to stir for another 15 minutes. A solution of ethyl 
crotonate was made by mixing 1.2 mL of ethyl crotonate with 1 mL ether. This solution was 
cooled to 0° C and added via syringe. The mixture was allowed to stir for 30 minutes and then 
placed stored at 4° C overnight to precipitate the potassium salt. Potassium salt was filtered and 
rinsed with hexanes and dried under vacuum to yield 1.907 g of the potassium salt. The 
potassium salt was dissolved in 25 mL DI H2O and 1 mL of glacial acetic acid was added. Resulting 
precipitate was collected by filtration and dried under vacuum to yield 1.3209 g of the diester. 
The diester was dissolved in a NaOH solution (2 M, 20 mL) and left at room temperature 
overnight. The solution was then acidified to pH 2 with HCl (12 M) and then placed on an ice bath 
for 1 hour. Precipitate was collected by filtration and dried under vacuum to yield 339.5 mg of 
diacid. 
Preparation of 3-(2-furyl)acrolenepyruvate (Chapter III, Scheme 4, 22) 
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The compound was synthesized as described in Chapter III. 
Steady-state kinetics and product identification.  
Based on our hypothesis that SwADC is an aldolase-dehydratase acting in an uncharacterized 
hydrocarbon degradation pathway, the activity of SwADC was tested with potential substrates 
including 2-oxo-3-hexenedioate (OHD), and 3-(2-furyl)acrolein and pyruvate. The assays were 
performed with 0.5 – 1 μM SwADC in 50 mM BIS-Tris pH 6.5, and various substrate 
concentrations. In aldol condensation reactions, sodium pyruvate was saturating (50 mM)  
The enzyme 4-oxalocrotonate tautomerase (4-OT) was used to produce OHD from 2-hydroxy 
muconic acid (2HM). Reactions contained 50 mM sodium phosphate buffer pH 6.5, 1 μM 4-OT, 
and 100 μM 2HM in a final volume of 0.5 ml. The production of 2-oxo-3-hexenedioate was 
monitored at 236 nm (ε = 6580 M-1 cm-1) or in UV-Vis spectra from 220 to 340 nm. Each assay 
was incubated without SwADC until the absorbance at 236 nm reached a maximum. At this point, 
SwADC was added to the mixture and the loss of absorbance at 236 nm was monitored. The assay 
was performed with 100 μM 2HM and different concentrations of SwADC (1, 2, or 4 μM). The 
assay also was performed using 5 μM SwADC and concentrations of 2HM ranging from 0 to 200 
μM. The activities of the K122A, K122M, and Y120F variants were tested using the same protocol. 
 
5.3 Results and Discussion 
Overall structure of SwADC.  
SwADC is a 28.8 kDa protein that, according to size exclusion chromatography, exists as a 
homotetramer in solution. The protein crystallized from 15% PEG 3,350 and 0.1 ‒ 0.2M 
magnesium formate, forming long, hexagonal rods on the order of 0.5 x 0.05 x 0.05 mm. These 
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crystals diffracted X-rays to ~2.0 Å-resolution.  Numerous, various proposed substrates have 
been soaked into SwADC crystals, as well as co-crystallized, however there has been no defining 
electron density detected from either method. Diffraction data were collected at the Life Science 
Collaborative Access Team (LS-CAT) beamline 21-ID-G at the Advanced Photon Source, Argonne  
National Laboratory. The data were processed in MOSFLM 29, 30 and scaled in SCALA 31. The 
structure of SwADC was 
determined by molecular 
replacement using the structure of 
a SbAD protomer (PDB ID 4ZBO) as 
the search model (see Table 19 for 
data collection and refinement 
statistics). SwADC crystals 
belonged to space group C2 with 4 
molecules in the asymmetric unit.  
As shown in Figure 34, the overall 
fold of the SwADC protomer is 
nearly identical to those of the 
prototypical Family I ADCs, as well 
as the recently described Family V enzymes like SbAD from Streptomyces bingchenggensis and 
MppR from S. hygroscopicus, which are not decarboxylases 12, 32. This fold, dubbed the β-cone 33 
or double barrel fold 34, consists of a large, antiparallel, 13-stranded β-sheet that forms the main 
barrel and folds back on itself to form the side barrel. Unlike prototypical ADCs that are active as 
Table 19. Crystallographic Data Collection and Model 
Refinement Statistics. 
SwADC 
  
resolution (Å) (last shell)a 38.39 ‒ 1.95 (2.02 ‒ 1.95) 
wavelength (Å) 0.9786 
no. of reﬂections 
             observed 
             unique 
 
334092 (27317) 
73627 (7275) 
completeness (%)a 100 (100) 
Rmerge (%)a,b 0.07611 (0.1883) 
multiplicity 4.5 (3.8) 
⟨I/σ(I)⟩a 13.92 (7.06) 
Model Refinement 
    
no. of reﬂections in the work set 73600 (7271) 
no. of reﬂections in the test set 3688 (349) 
Rcryst (Rfree) 0.1719 (0.2068) 
no. of residues 1025 
no. of TLS groups 27 
average B factor (Å2)c 
               protein atoms 
               solvent 
 
35.94 
35.84 
root-mean-square deviation 
               bond lengths (Å) 
               bond angles (deg) 
 
0.012 
1.28 
Ramachandran statistics 
(favored/allowed/outliers) 
 
98.5/1.5/0 
aValues in parentheses apply to the high-resolution shell 
indicated in the resolution row.  
bR = ∑(||Fobs| − scale ×| Fcalc||)/∑|Fobs|. cIsotropic equivalent B 
factors, including the contribution from TLS reﬁnement. 
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homododecamers, SwADC has a tetrameric quaternary structure similar to SbADC and MppR 
(Figure 34). 
 Figure 34. (A) Rendering of the solvent-
accessible surface of SwADC showing 
the extensive tetramer interface 
formed by the long, interdigitating 
loops (top). This interface is repeated 
on the back side with the blue and pale 
blue protomers. The pair of dimers is 
held together (bottom) by short loops 
that appear to “clip” the two dimers 
together to form the tetramer. (B) The 
ribbon diagram showing a single 
protomer is oriented like the yellow 
protomer in panel A. The main barrel 
of the β-cone fold is colored pale blue, 
with the “side barrel” colored green. 
The dimer interface loops are colored 
yellow, and the loops forming the 
interface between the dimers are 
colored orange. The section of the 
polypeptide that is colored red is the 
“active site loop” that may control 
access to the active site. The catalytic 
Lys122 is shown as a ball-and-stick 
representation with purple carbon 
atoms. 
Although the tetramer in Figure 34 does not contain a ligand, only conserved waters, chains A 
and C, represented by the pale yellow and pale blue protomers, had different active site 
conformations than chains B and D, shown as orange and dark blue. Interestingly, the tetramer 
for SwADC is a dimer of dimers. The two dimer pairs from each dimer are different, as opposed 
to the two dimers differing from one another. Figure 35 illustrates these different active site 
conformations, with the corresponding schematic representations and the relevant distances 
provided in Figure 36. 
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Figure 35. The two different active sites of SwADC, represented by (A) and (B), respectively. (A) Stereoview of the active site 
in the SwADC structure showing conserved waters (refer to Figure 36 for relevant hydrogen bonding interactions and their 
distances). (B) One putative new water molecule has been recruited by Glu84. In both panels, the experimental 2|Fo|−|Fc| 
electron density map (magenta) and the simulated annealing composite omit 2|Fo| − |Fc| electron density map (green), both 
contoured at 1.0σ, are drawn with a 2.0 Å radius around each atom of Lys122 and select water molecules. This figure and 
subsequent figures showing crystallographic structures were rendered with the POVSCRIPT+35 modification of MOLSCRIPT36 
and POVRAY. 
122 
 
Chains A and C (Figures 35 A and 36 A, conformation A) has three ordered water 
molecules bound. In chains B and D (Figures 35 B and 36 B, conformation B) water molecule 3 
from conformation A has been retained, water molecules 1 and 2 have been lost, and a new 
water molecule (labelled “4” in Figures 35 B and 36 B) is bound to Glu84. However, the biggest 
difference between the two active site conformations is that in conformation A, Arg114 exists in 
a single conformation as evidenced by the well-defined electron density, and Tyr120 samples 
multiple conformations such that much of the associated electron density is missing. In 
conformation B, the opposite is true. Tyr120 takes a single conformation and the guanidinium 
group of Arg114 is disordered. These two residues are not connected by hydrogen bonding or 
van der Waals interactions of their side chains, nor do they communicate through a water-
mediated hydrogen bond network. In addition to this, the indole of Trp24 flips about 90° between 
conformations A and B, and Val106 rotates about 180°. Perhaps all these changes are based on 
a concerted change in the tetrameric structure, such that one version of the active site is better 
 
Figure 36. Schematic views of (A) one of the active sites of SwADC and (B) the other conformation showing potential hydrogen 
bonding interactions and their distances (in Angstroms) in green. 
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configured for catalysis than the other. However, the conformations of the active sites are lowest 
energy forms of the protein under crystallization conditions, and so these subtle differences may 
not be physiologically relevant. Thus, SwADC may be a cooperative enzyme, though our 
preliminary kinetics on admittedly poor substrates do not suggest that this is the case. 
 Functional characterization. The biochemical function of SwADC remains elusive, though there 
are indications that it can function as a pyruvate 
aldolase-dehydratase. As a Family V enzyme of 
the ADCSF, the binding constants of pyruvate 
and other α-keto acids were measured (Table 
20). The KD of pyruvate is twice as high as that 
for SbAD. Surprisingly, given the number of rotatable bonds, 2-oxo-adipate has a somewhat 
lower KD, suggesting that the enzyme might have a preference for longer, aliphatic side chains on 
the α-keto acid (Table 20). Based on the space available in the active site and the array of residues 
lining the pocket, it seemed that a 6-8 carbon long di-carboxylic acid might be a viable substrate. 
Accordingly, 2-oxohex-3-enedioate (generated by 4-oxalocrotonate tautomerase from 2-
hydroxymuconic acid) was tested for activity with SwADC (Scheme 9). When 100 µM OHD was 
incubated with 10 µM SwADC, there was a steady decrease in the absorbance due to cleavage or 
Table 20. Binding constants for α-keto acids with SwADC. 
α-keto acid KD (mM) 
pyruvate 10.1 ± 0.9 
2-oxoglutarate 11.0 ± 1.4 
2-oxoadipate 5.9 ± 0.7 
Scheme 9. 2-hydroxymuconic acid (2HM) reacts with 4-oxalocrotonate tautomerase (4-OT) to produce 2-oxohex-3-enedioate 
(OHD). SwADC then reacts to form an aldol. 
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loss of conjugation of OHD (Figure 37). The 
rate of decrease was dependent on both 
the concentration of OHD and the 
concentration of enzyme (data not 
shown). The steady state kinetics of this 
reaction were analysed for the wild type, 
as well as three active site mutants: 
Tyr120Phe, Tyr120Phe/Phe248Tyr, and 
Asn118Glu (Table 20). The mutants were 
selected for their possible catalytic and/or 
binding roles based on homology to SbAD. Tyr120 is one of the residues that is disordered in one 
conformation, but not the other. Perhaps Tyr120 needs to undergo conformational change in 
order for a reaction to occur. To test this idea, Tyr120 was mutated to a Phe, as there is a Phe in 
this position in SbAD. Phe248 was mutated to Tyr as it matches the residue in SbAD, which is 
Tyr252. Phe248Tyr could not be obtained in soluble form, however the double mutant 
Tyr120Phe/Phe248Tyr expressed and purified well, and the pair of mutations make this variant  
 more like SbAD. Lastly, Asn118 was mutated Glu, again to match SbAD.  
Table 20. Steady state kinetics for SwAD WT and active site mutants with OHD, monitored at 
236 nm. 
SwADC kcat, OHD (sec-1) KM, OHD (µM) kcat/KM (M-1 sec-1) 
WT 0.010 ± 0.001 66.4 ± 16.3 151 ± 40 
Y120F 0.042 ± 0.006 281.1 ± 67.2 149 ± 42 
Y120F F248Y 0.018 ± 0.002 340.4 ± 57.5 53 ± 11 
N118Q No activity - - 
 
Figure 37. 100 µM 2HM was treated with 1 µM 4-OT for 20 min 
before 10 µM SwADC was added. Scans were recorded every 4 
minutes at 25 °C. The λ300nm is remaining 2HM, and λ236nm is OHD. 
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In other crystal structures (data not 
shown), Arg114 appears to wave around the 
active site, while Asn118 has continuous 
electron density. SbAD, however, naturally 
has Gln at this position, and continuous 
electron density for Arg114 and Glu118. We 
proposed that the longer side chain of Glu 
for Asn118Glu may fix Arg114 in place, 
altering binding or catalysis. Based on the results in Table 20, Tyr120Phe is about 4 times faster 
at turnover, however the KM is higher. These two factors compensate to attain the same pseudo-
second order rate constant. Perhaps the substrate binds Tyr120Phe in a different manner 
resulting in a faster reaction. The double mutant had the lowest kcat/KM, however all of the SwADC 
variants reacted quite slowly with OHD. The KM values suggest that OHD does not bind terribly 
well. A seven-carbon compound like oxo-heptene-dioate, rather than the six-carbon OHD, could 
conceivably fill the active site more completely and be a more efficient substrate. 
To that end, 5-carboxymethyl-2-hydroxymuconic acid (CHM) was isomerized by CHM 
isomerase, to yield 5-(carboxymethyl)-2-oxo-3-hexene-1,6-dioic acid (COHED). COHED was then 
decarboxylated to 2-oxo-3-heptenedioic acid. When 2-oxo-3-heptenedioic acid was incubated 
with SwADC, there was a time-dependent reduction in absorbance at all wavelengths, similar to 
what was observed with OHD (Figure 38). The reaction was not characterized by steady state 
kinetics as both CHM, CHM isomerase, and COHED decarboxylase were difficult to produce. 
Efforts focused instead on identifying the product of the reaction with OHD by mass spectroscopy 
Figure 38. 10 µM Swit reacted with 2-oxo-3-heptenedioic acid 
for 2 minute scans at 30 °C. 
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(MS) and nuclear magnetic 
resonance (NMR) (Appendix II). 
Based upon MS data, it appears 
unlikely that SwADC performs retro-
aldol cleavage of OHD. Instead, it 
appears to simply hydrate the 
double bond to give the aldol. Vinyl 
pyruvate (8, Scheme 10 B) was also 
treated with SwADC and the reaction 
mixture analyzed by MS. As with 
OHD, only the aldol product could be detected; there was no evidence of other products. There 
was also no evidence of the aldol forms of OHD or 8 in standards that had not been incubated 
with SwADC. The NMR data were inconclusive owing to the complicated spectra arising from the 
mixture of compounds present. No cleavage products of either substrate were detected by 
reverse phase HPLC. 
Based on the close relationship between SwADC and SbAD, cinnamaldehyde and pyruvate 
were used to test for aldol condensation activity in SwADC. SwADC was not able to catalyze the 
aldol condensation 
with these 
substrates, likely 
because the aromatic 
group of cinnamaldehyde is too bulky and/or lipophilic for the SwADC active site. To test this, 3-
 
Scheme 10. The proposed reaction in (A) is observed in Figure 38. The 
reaction in (B) has been confirmed by mass spectroscopy as well. 
 
Scheme 11. Reaction tested for SwADC based on the results of SbAD. 
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(2-furyl)acrolein was used as the acceptor substrate (Scheme 11). Both the condensation and the 
retro-aldol cleavage (catabolic) reactions were characterized by steady state kinetics (Table 21). 
It is difficult to say if the breakdown direction stops at the aldol, or a full retro-aldol cleavage 
occurs. The aldol is difficult to detect via MS, and pyruvate does not appear on NMR spectra or 
MS data for the catabolic process yet the fact that the enzyme catalyzes the aldol condensation 
reaction between pyruvate and 10 to give the enone suggests that it should be able to catalyze 
the retro-aldol reaction as well.  
Table 21. Steady state kinetics for Scheme 11. SwADC was 0.5 – 1 µM. Reactions took place at 25 °C in 50 mM BIS-Tris pH 6.5 
and monitored at 390 nm. 
SwADC kcat,10 (sec-1) KM,10 (µM) kcat/KM (M-1 sec-1) kcat,12 (sec-1) KM,12 (µM) kcat/KM (M-1 sec-1) 
WT 0.084 ± 0.006 2.99 ± 0.65 2.8 ± 0.6 x 104 0.09 ± 0.02 42.02 ± 13.99 2.1 ± 0.9 x 103 
N118Q 0.068 ± 0.005 3.64 ± 0.82 1.9 ± 0.4 x 104 No Activity 
Y120F F248Y 0.041 ± 0.003 1469.8 ± 252.2 27.9 ± 5.2 No Activity 
 The wild type SwADC and the two mutants tested all functioned in the aldol condensation 
reaction (synthetic direction), with the Asn118Glu variant turning over at about the same rate as 
the WT, and the Tyr120Phe/Phe248Tyr variant only slightly slower. Likewise, the WT and 
Asn118Glu SwADC had the same Michaelis constant, indicating that the mutation likely did not 
affect substrate binding. The Y120F/F248Y double mutant has a KM value for 10 almost 500-fold 
higher than that of the WT enzyme. Since it was not possible to test both single mutants, it is not 
clear whether this effect is due to Tyr120, Phe248, or the combination of the two. It is clear, 
however, that the double mutant does not bind 10 well. Interestingly, only the WT enzyme 
catalyzed the retro-aldol cleavage (catabolic direction) of 12. Again, since the signal loss at 390 
nm was the method of detection, it is not possible to tell if the reaction stopped at the aldol, 
which would eliminate the conjugation that gives rise to the absorbance signal. Interestingly, 
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neither of the mutants were active. Perhaps they do not hold the substrate in the correct 
orientation for reaction, or their KM is greater than 10 mM. 
In any case, the function of SwADC is certainly distinct from those of the classical ADCs, 
as well as the Family V enzymes SbAD, which is an aldolase-dehydratase 32, and MppR, which 
likely catalyzes the cyclization of a highly oxidized arginine derivative 12. Comparisons of the 
active sites shed light on the reasons for this (Figures 39 and 40). The residues responsible for 
Schiff base chemistry are conserved: the active site lysine and the likely acid/base catalyst 
glutamate that is within hydrogen bonding distance. In SwADC numbering, Arg114, Asn118, and 
Val106 are the same between SwADC and MppR. However, there are significant differences, as 
observed in Figure 39. 
Figure 39. Stereoview comparing MppR and SwADC. The green peptide chain is MppR, and the blue is SwADC. The active site 
lysine and likely acid/base catalyst glutamate are labelled according to SwADC, and are conserved in both proteins, along with 
R114 and N118. There are numerous differences, however observed throughout the rest of the model. For instance, the 
switching of Trp and Phe on the top portion, and the Met in MppR. Although the carboxylate-binding site appears to be 
conserved, other residues in the active site aside from those that contribute to forming a Schiff base intermediate, are not. 
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A comparison of SwADC and SbAD (Figure 40) shows K122 and E84 are conserved, contributing 
to Schiff base intermediate in the mechanism. Similar to Figure 39, although Arg114 is conserved, 
it is facing in the opposite direction. We can now see the difference near Arg114 for the Asn118 
in SwADC and Glu118 in SbAD. Mutating position 118 in either enzyme alters the steady state 
kinetics, and suggests a role in catalysis and/or substrate binding. The tertiary structures of 
SwADC and the known decarboxylases are extremely similar (RMSD <2.0Å for all common Cα 
atoms). The loss of decarboxylase activity is the result of a series of key amino acid substitutions 
Figure 40. Stereoview comparing SbAD and SwADC. The dark blue peptide chain is SbAD, and the pale blue is SwADC. The 
active site lysine and likely acid/base catalyst glutamate are conserved in both proteins, along with Arg114. There are 
numerous differences, however observed throughout the rest of the model. Although the carboxylate-binding site appears to 
be conserved, other residues in the active site aside from those that contribute to forming a Schiff base intermediate, are not. 
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and subtle structural rearrangements. Thus, there is significant reaction diversity even within a 
single family of the ADCSF. 
 
5.4 Conclusions  
While SwADC is very weak with the substrates tested, it can catalyze the aldol 
condensation and subsequent dehydration of pyruvate and a number of aldehydes to yield the 
corresponding enones. However, MS data points towards hydration only in the catabolic 
direction, noted by the hydrations of vinyl pyruvate (2) and OHD (8). Future work will focus on 
characterizing the other members of the proposed catabolic gene cluster with the goal of 
identifying the physiological substrate for this catabolic pathway.  
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CHAPTER VI: CONCLUSIONS 
 Despite the retention of an overall tertiary fold and a Schiff base intermediate in their 
mechanisms, there is significant diversity in terms of substrate specificity and the reactions 
catalyzed among enzymes of Family V of the ADCSF. MppR was the first Family V enzyme to be 
characterized. It was shown to catalyze the cyclization of 4-hydroxy-2-ketoarginine, as well as 
aldol condensation of 4-imidazolecarboxaldehyde and pyruvate with subsequent dehydration to 
yield the enone 1. The latter of these two reactions is also catalyzed by SbAD 2, an aldolase-
dehydratase from Streptomyces bingchenggensis that will accept a range of aldehyde substrates  
and SwADC, an enzyme of unknown function from Sphingomonas wittichii. Although all three 
enzymes can catalyze the aldol condensation reaction, it is only the primary reaction for SbAD. 
In addition, there are differences in the substrate preferences in all cases. Subtle differences in 
the residues lining the active sites of these 3 enzymes accounts for their different reactions and 
substrate specificities. SbAD is most efficient with aldehydes having a bulky, substituted-aromatic 
group, like 4-nitrocinnamaldehyde, whereas SwADC was only observed to catalyze the reaction 
with the smaller, more polar 3-(2-furyl)acrolein. Transient kinetic studies of the reaction of 
cinnamaldehydes with pyruvate catalyzed by SbAD, together with KIE analysis, allowed us to 
propose a mechanism for this ADCSF enzyme. The order of addition was not conclusive from 
transient kinetics alone, so inhibitors were used to determine that the mechanism is ordered 
sequential with pyruvate likely binding first. Mutation of residues in the active site of SbAD 
identified the key residues for catalysis. Binding constants measured for pyruvate and 
cinnamaldehyde show that none of the residues tested had a significant effect on substrate 
binding, suggesting that substrate binding is driven more by van der Waals forces and size/shape 
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complementarity between the substrate and active site. Tetramer interface mutants also suggest 
that SbAD may undergo a conformational change during catalysis, though there is no evidence 
of cooperativity in any of the kinetics data. The enzyme Swit_4259 from Sphingomonas wittichii 
(SwADC) also maintained the overall fold of ADC, but appears to function as a hydratase or 
aldolase dehydratase, as evidence for the retro-aldol reaction is lacking. Based on the collected 
results, SwADC appears to violate the principle of reversibility, whereby the reaction catalyzed in 
one direction should also be catalyzed in the reverse. All three enzymes in Family V lack the key 
decarboxylase residues found in Family I: the arginine that orients the acetoacetate in the active 
site for nucleophilic attack, and the second glutamate, whose negative charge aids in 
decarboxylation. The loss of those key residues, but retention of the lysine nucleophile and likely 
acid/base glutamate, might lead one to believe that the Family V enzymes would have similar 
substrate specificities and activities. However, even these three incredibly similar enzymes 
illustrate the variety of reactions catalyzed in Family V alone. All three enzymes are also found in 
organisms noted for secondary metabolism, and based on gene context, may aid in those 
biosynthetic (SbAD) or aromatic hydrocarbon degradation (SwADC) processes. 
 While much has been learned about SbAD and SwADC, several outstanding questions 
remain. The biological function of SbAD is still unknown. Studying a close homolog from another 
bacterium might offer clues to its biological function. To this end, we have identified two species 
with SbAD homologs having greater than 50% sequence identity: Burkholderia terrae 
(WQE_44883, 57%) and Actinobacteria bacterium OK006 (OK006_7770, 91%).  Real time PCR 
could be used to identify growth conditions for one or both species that result in expression of 
the SbAD homologs. Comparative metabolomics experiments using the instrumentation in the 
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Shimadzu Laboratory for Advanced and Analytical Chemistry could identify compounds that are 
only present when these genes are expressed. Then, performing the same experiment in knock-
out strains, we should be able to identify a small number of compounds that might be associated 
with the SbAD homolog. Another outstanding question regarding catalysis in SbAD is the number 
of protons moving in the reaction. This might be answered with a proton inventory experiment, 
which can detect the coupling of several proton transfers in a single step 3. Since the pH rate 
profile has been done, a pD profile would be needed next. The pH/pD at which the reactions in 
H2O and D2O give the same turnover number would be optimal for the proton inventory, 
detecting how many protons are in flight during turnover. The methods to investigate SbAD can 
also be applied to SwADC. SwADC requires more substrate specificity experiments, transient 
kinetics to see if there is any burst phase in the reaction, and single turnover to gather rate 
constants. Another method to detect an intermediate could be to incubate the enzyme with 
substrate, use NaBH4 to reduce the imine to an amide, and then use mass spectroscopy to 
determine what has bound. In the case of an isomer bound, a chiral column for HPLC may be able 
to distinguish the compound based on signal, retention time, and comparison to known 
compounds. Overall, Family V contains enzymes that catalyze a variety of reactions; it may be 
that the only factor common to most ADCSF enzymes is the Schiff base chemistry. This work has 
contributed to our knowledge of the structure-function relationship in proteins and could 
potentially increase the reliability of function annotations for ADCSF sequences in genome 
sequence databases. 
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APPENDIX I: SbAD 
Genomic context of the gene encoding Sbi_00515. 
 
Gene 
Product 
Length 
(aa) 
 Annotation Closest characterized homolog Identity 
(%) 
Sbi_00514 160 + Urease accessory protein UreD, Streptomyces mirabilis 79 
Sbi_00515 265 - Acetoacetate decarboxylase MppR, Streptomyces 
hygroscopicus 
39 
Sbi_00516 205 + 2,4-DAPG biosynthesis 
transcriptional repressor PhlF 
Mycofactocin system 
transcriptional regulator, 
Rhodococcus sp. AD45 
36 
Sbi_00517 219 - TetR family transcriptional 
regulator 
None ~ 
Sbi_00518 133 + Stress responsive alpha-beta 
barrel domain protein 
None ~ 
Sbi_00519 294 + Taurine catabolism dioxygenase Alpha-ketoglutarate-dependent 
taurine dioxygenase, 
Burkholderia caribensis MBA4 
46 
Sbi_00520 188 + Hypothetical protein FcoT, type III thioesterase, 
Mycobacterium tuberculosis 
41 
Sbi_00521 133 + Acyl carrier protein MelD protein, Melittangium 
lichenicola 
34 
Sbi_00522 1813 + Modular polyketide synthase None ~ 
Sbi_00523 485 + Beta-ketoacyl synthase Ketosynthase-acyltransferase di- 
domain from module CurL of the 
curacin A polyketide synthase, 
Moorea producens 3L 
41 
Sbi_00524 524 + Long chain fatty acid-CoA 
ligase 
Dicarboxylate-CoA ligase PimA, 
Streptomyces sp. AA4 
54 
Sbi_00525 437 + Cytochrome P450 Cytochrome P450 eryF, 
Saccharopolyspora erythraea 
36 
Sbi_00526 254 + Acetoacetate decarboxylase Acetoacetate decarboxylase, 
Clostridium acetobutylicum 
ATCC 824 
56 
Sbi_00527 514 - Hypothetical protein None ~ 
Sbi_00528 528 - Hypothetical protein None ~ 
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APPENDIX II: SwADC 
(LC)MS; Negative polarity Swit WT 
Sample m/z Intensity 
Buffer (20mM Ammonium acetate pH 7.0) 87.15 226 
Buffer (20mM Ammonium acetate pH 7.0) 
[intensity > 300] 
105.20 
189.10 
245.45 
301.80 
361.45 
980 
340 
440 
400 
550 
2mM Sodium pyruvate standard 87.20 2865 
2mM 2KP standard 113.20 4000 
2KP + Swit WT 
 
87.15 
113.20 
131.20 
558 
2100 
3500 
2KP + Swit Y120F (ZM -80°C stock) 87.20 
113.20 
131.20 
365 
2400 
5000 
2mM 2-HM 113.20 
157.15 
173.15 
4000 
16000 
89 
2mM 2-HM + 4-OT 113.20 
131.20 
157.15 
173.15 
175.15 
4000 
400 
10672 
117 
390 
2mM 2-HM + 4-OT + Swit WT 87.20 
113.20 
131.20 
157.15 
173.15 
175.15 
700 
1500 
4500 
3000 
213 
6152 
2mM 2-HM + 4-OT + Swit Y120F (ZM -80°C 
stock) 
86.95 
113.15 
131.20 
157.15 
173.10 
175.10 
369 
1357 
1000 
4364 
265 
7960 
2mM CHM 215.15 
217 
230.20 
44602 
4000 
168 
2mM CHM + CHMI 195.05 
215.15 
217 
231.15 
11600 
725 
3129 
875 
2mM CHM + CHMI + Swit WT 195.05 
215.15 
15500 
2141 
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217.05 
231.15 
187.15 
189.10 
3548 
1162 
646 
2678 
2mM CHM + CHMI + Swit Y120F 189 
195.05 
215 
217 
231.15 
2000 
22000 
2000 
4100 
1500 
2mM CHM + CHMI + COHED 169.90 
213 
111.10 
171.15 
189 
195.05 
217 
401 
665 
6600 
3200 
800 
13100 
2615 
2mM CHM + CHMI + COHED + SbAD WT 217 
171.15 
195.05 
189.05 
231.1 
3000 
3800 
18200 
2327 
800 
2mM CHM + CHMI + COHED + SbAD Y120F 171.05 
189.05 
195.05 
217.05 
231.15 
6200 
4100 
22800 
4000 
1600 
2mM CHM + CHMI + COHED + OHEDH 171.15 
189.05 
195.05 
215.10 
217.05 
231.10 
6200 
6200 
15500 
2100 
4100 
1500 
 
10 µL injections.  
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